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BIAS AND VARIABILITY IN IMAGE-BASED VOLUMETRIC 
YTTRIUM-90 DOSIMETRY 
Wendy Siman, M.S. 
Advisory Professor: S. Cheenu Kappadath, Ph.D. 
90Y-microsphere therapy has been widely accepted as a treatment option for both 
primary and metastatic liver tumors where the patients are ineligible for surgical resection 
and external beam radiation therapy.  The prognosis of untreated patient having liver cancer 
is very poor with life expectancy less than a year at advance stage.  Hence the ability to 
predict treatment efficacy right after the treatment from post-therapy imaging will help 
personalize treatment strategies and achieve better outcome.  Such prediction can be modeled 
from correlation of dose and tumor response metrics. 
It has been shown that local dose deposition method can generate dose map from 
90Y emission images with accuracy comparable to dose-point kernel and Monte Carlo 
simulation methods.  The bias and variability of the input images remain to be the weakest 
link in volumetric dosimetry.  The objectives of this dissertation project were to improve 
image-based volumetric 90Y dose quantification using current commercially available 
systems and to determine its limitation (bias/variability). 
We have developed a practical image reconstruction method for 90Y bremsstrahlung 
SPECT/CT (bSPECT/CT) images with CT attenuation correction and energy-window based 
background compensation.   Although the volumetric quantitative accuracy of our 
bSPECT/CT images is limited by partial volume effect, the images can be used to accurately 
vi 
 
quantify the total 90Y activity delivered to the patient, which allow gross treatment delivery 
verification and limited outcome prediction. 
We have also characterized the accuracy and variability of volumetric 90Y 
dosimetry calculated from count-limited 90Y-PET/CT images. Knowledge of overall errors 
(systematic and random) in volumetric 90Y dosimetry is important to derive statistically 
significant dose-response model, which in turn allowing prediction of treatment outcome and 
personalization of treatment strategy. 
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Chapter 1: Introduction 
1.1.  Background 
Liver cancer is the second leading cause of cancer-related death; accountable for 
745,000 deaths in 2012 (9.1% total).  The prognosis for liver cancer is very poor with the 
mortality/incidence ratio of 0.95 (1).  In the United States, the liver-cancer incidence and 
mortality of 39,230 and 27,170 are estimated in the year of 2016 (2).  Similar to the world-
wide prognosis, the prognosis of liver cancer in the US is also very poor with the 1- and 5-
year survival rates of 44% and 17%.  About 75% of the liver cancer cases are hepatocellular 
carcinoma (HCC) cases.  Liver is also a common site for metastatis from tumors in organs 
that supply blood to portal vein, e.g., colorectal and pancreatic tumors. 
Although surgical resection offers the best prognosis for liver-cancer patient, only < 
25% of the patients are eligible for the procedure (3–6).  These patients are usually not 
eligible for external beam radiation therapy because of radiosensitivity of both tumor and 
normal tissue.  Radioembolization using radionuclide-doped microsphere is devised to 
exploit the difference in perfusion between normal liver and liver tumors (both HCC and 
metastatic) (7).  In normal liver tissue, 70%–80% of the blood is supplied by the portal vein 
and the rest is supplied by the hepatic artery.  In contrast, 80%–100% of the blood supply to 
liver tumor comes from the hepatic artery (8).  This unique perfusion of the tumor allows 
selective delivery of radionuclide-doped microspheres, using intra-arterial technique, to the 
tumor while sparing the normal liver tissue.  Note that the distribution of the microspheres is 
mechanistic instead of biochemical distribution; hence the treatment technique is called 
selective internal radiation therapy (SIRT) instead of targeted radionuclide therapy (TRT). 
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Currently there are two commercially available microspheres products: glass 
microspheres (TheraSphere™; BTG Biocompatibles Ltd, Farnham, UK) and resin 
microspheres (SIR-Spheres™; Sirtex Medical, Sydney, Australia).  Resin microspheres are 
FDA approved to treat colorectal cancer liver metastates, while glass microspheres are under 
a humanitarian device exemption from the FDA to treat HCC.  The differences in efficacy 
and toxicity of these two sphere types are subject to ongoing debate (9, 10), although recent 
studies show that the overall patient survival treated using either spheres is very comparable 
(11). 
Both resin and glass microspheres are doped with Yttrium-90 (90Y).  90Y is selected 
to deliver the radiation therapy because of its attractive therapeutic properties.  90Y is 
effectively a pure β- emitter with maximum and average β- energy of 2.28 and 0.934 MeV, 
with half-life of 64.2 hours.  This energy spectrum corresponds to maximum and average 
penetration range of < 11 mm and < 4 mm in tissue, respectively.  Hence, the 90Y 
microspheres deposit their energy locally at their “target” location, which allows normal 
tissue sparing during the radiation treatment. 
Treatment planning for 90Y microspheres is done using surrogate 99mTc-MAA 
(macro aggregated albumin). Many studies have shown that distribution of MAA is not a 
consistent and reliable predictor of microsphere distribution (12, 13); therefore a direct 
imaging of post 90Y-microsphere therapy is needed to confirm the delivery of 90Y-
microsphere distribution (qualitative imaging) and to predict the treatment outcome 
(quantitative imaging). 
Although it is desirable from safety point of views (normal tissue sparing and 
patient release), as a pure β- emitter, 90Y presents a very unique challenge for direct 90Y 
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imaging.  90Y planar and SPECT images can be acquired by imaging the bremsstrahlung 
photons, produced as the β- particles interact with matter (liver parenchymal).  90Y 
bremsstrahlung imaging is very challenging (Chapter 2) mainly due to the absence of 
photopeaks (γ and/or fluorescence x-ray) and sub-optimal hardware.  Alternatively, 90Y 
decay process also yield very low branch of 32 ppm positron emission, produced via internal 
pair production.  The annihilation photons can be imaged using PET imaging, which poses 
very unique challenges as well due to very low signal (Chapter 3–5). 
 
1.2.   Purpose statement 
The long term goal of this project is to assess the efficacy (tumor response and 
normal tissue toxicity) of 90Y-microsphere therapy by correlating image-based volumetric 
dose quantification to tumor response and normal tissue complications, thus leading to 
treatment-strategy personalization and better patient outcome.  The objectives of this 
dissertation project were to improve image-based volumetric 90Y dose quantification using 
current commercially available systems and to determine its limitation (bias/variability). 
A period of 4–8 months is required to reveal whether or nor not the tumor is 
responding to 90Y-microsphere treatment (14).  In normal clinical workflow, the follow-up 
imaging procedure (e.g. CT, MR, 18F PET/CT, 99mTc-MAA SPECT/CT) to evaluate 
treatment response is scheduled about 3 months after 90Y-microsphere therapy, the earliest; 
while patients with advance liver cancer disease (both HCC and metastases), if left untreated, 
usually survive for less than 6–12 months (15–18).  Hence the ability to predict the efficacy 
3 
 
of treatment from post-therapy 90Y imaging will allow personalization of treatment strategy, 
which will result in better outcome for the patient. 
To realize this precision-medicine approach, several groups have used image-based 
volumetric dosimetry (19–23) to derive the dose-response model for 90Y-microsphere 
therapy.    90Y dose maps have been calculated from either 99mTc-MAA SPECT/CT, 90Y 
bSPECT/CT, or 90Y PET/CT images.  At the current state of commercially available 
technology, there seems to be a general agreement that 90Y PET/CT images are the better 
estimation of 90Y activity (or dose) distribution.  Studies have shown that 99mTc-MAA 
(macro aggregated albumin) is not a consistent and reliable surrogate of 90Y-microsphere 
distribution (12, 13); while  90Y bSPECT/CT images have been shown to be inferior in image 
resolution, image contrast, and hence volumetric quantitative accuracy compared to 90Y 
PET/CT (24–26). 
Nevertheless, in the United States, majority of post-treatment 90Y imaging 
procedures, which are important to verify the treatment delivery, are done on SPECT/CT 
scanners.  Most recent development in bremsstrahlung SPECT/CT (bSPECT/CT) image 
reconstruction has shown that with incorporation of physics modeling using Monte Carlo 
simulation, it is possible to generate accurate quantitative bSPECT/CT images (27, 28).  
However, these advance techniques are not widely available for clinics where 90Y-
microsphere therapies are done.  In the specific aim 1 of this dissertation project, we have 
developed a practical method, using commercially available SPECT/CT systems, to 
reconstruct bSPECT/CT images with improved image quality and improved activity 
quantification. 
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Recent 90Y-PET-based dose-response studies have not been able to show a 
consistent and statistically significant relationship between dose metrics (D70 and/or Dmean) 
and tumor response to 90Y-microsphere therapy (22, 23).  Volumetric dosimetry that 
incorporates radiobiological modeling is suggested to have improved dose-response model 
(29–31).  In addition, dose-response model also needs stratification based on microsphere 
type, tumor type, dosimetry and response quantification methods (30, 32).  Incorporation of 
radiobiological modeling requires information of 3D dose distribution, which can be 
estimated from 90Y PET/CT images (33–35).   The performance of volumetric 90Y dosimetry 
calculated from degraded 90Y PET/CT images, however, has not been characterized.  In 
specific aim 2–4, we characterized and optimized the performance of PET-based volumetric 
dosimetry.  
 
1.3.  Hypothesis and aims  
1.3.1.  Central hypothesis 
The central hypothesis of this dissertation is that optimization of 90Y emission 
image reconstruction, using current commercially available imaging systems, can maintain 
the overall errors (systematic and random) in volumetric dose quantification to < 20% in 
clinically relevant imaging conditions. 
 
1.3.2.   Specific aim 1 
SA 1: Develop practical 90Y bremsstrahlung SPECT/CT imaging protocol. 
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Several groups (27, 28) have shown that Monte-Carlo simulation can accurately 
model the object attenuation, scatters, and collimator-detector response to reconstruct 
quantitative bresmsstrahlung SPECT/CT (bSPECT/CT) images with quantification error of 
mean activity concentration < 10%.  These advance image reconstruction method, however, 
are not commercially available and cannot be readily implemented in clinical practice, 
especially in clinics that are not associated with academic hospital, a common practice in the 
United States. 
The objective of this aim is to improve image quality and 90Y dosimetry 
quantification of bSPECT/CT images using a commercially available imaging system.  We 
tested the working hypothesis that energy-window based “background” compensation can be 
used to improve volumetric dose quantification and image quality in 90Y bSPECT/CT. 
In this aim, we developed a practical and simple methodology to determine 
bremsstrahlung imaging energy window (EW) and to correct for attenuation (CT-based) and 
“background” signal (EW-based).  This methodology can readily be applied in clinical 
practice to improve image quality and quantification of 90Y bSPECT/CT images. 
Research design: 
• SA 1.1: Determine the imaging EW for 90Y bremsstrahlung imaging 
• SA 1.2: Develop the EW-based background compensation model 
• SA 1.3: Optimize the image reconstruction parameters 
• SA 1.4: Establish the count-to-activity calibration factor 
 
1.3.3. Specific aim 2 
SA 2: Optimize 90Y PET/CT image reconstruction for volumetric dose quantification. 
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Volumetric dosimetry has been calculated from 90Y PET images (20, 22, 25).  Recent 
studies on image reconstruction-parameters optimization for quantitative 90Y PET imaging 
(24, 36–39), however, have still been based on mean-activity-concentration recovery 
coefficient as the objective function, which is more relevant to diagnostic dosimetry and 
detection tasks. 
 The objective of this specific aim was to improve quantification of volumetric 90Y 
dosimetry by optimizing the image-reconstruction protocol.  Our working hypothesis for this 
aim was that using dose volume histogram estimate (DVH’), instead of mean dose recovery 
coefficient, as the optimization objective function would result in smaller errors in 3D dose 
distribution. 
Traditional objective function of mean dose recovery coefficient can only be used to 
optimize the number of equivalent iterations and it does not take into account the change of 
3D dose distribution due to image noise.  In this aim, using errors of DVH’ as the objective 
function, we were able to concurrently optimized the number of equivalent iterations and the 
filtration full width at half maximum and, consequently, minimized the errors in volumetric 
quantification of 90Y dose distribution.   
Research design: 
• SA 2.1: Optimize the number of equivalent iterations (subset × iteration) based on 
convergence of mean dose recovery coefficient (RC). 
• SA 2.2: Optimize the reconstruction parameters (equivalent iterations and filter FWHM) 
based on the errors in DVH’. 
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1.3.4.  Specific aim 3 
SA 3: Determine the errors and variability of volumetric dose quantification from 90Y 
PET/CT images 
Volumetric 90Y dose has been quantified (22, 23, 25) using cumulative dose volume 
histogram calculated from 90Y PET images (DVH’) and has been used to empirically derive dose-
response relationship to predict treatment outcome.  90Y PET images, however, are subject to image 
degrading factors such as partial volume effect, image noise, and motion blur (40).  Consequently, the 
DVHs’suffer from errors due to these degrading factors.  While these factors degrade all emission 
imaging, 90Y PET imaging presents a unique challenge in the extremely low signal (positron yield of 
32 ppm).   
Despite increased use of 90Y PET images for volumetric 90Y dosimetry, the impact of very 
low signal on the errors, both systematic and random, in the resulting DVH’ and it summary metric 
(e.g., Dmean and D70) has not been thoroughly evaluated. 
The objective of this aim was to characterize the systematic and random errors in 
quantification of 90Y volumetric dose distribution from 90Y PET images.  The working 
hypothesis of this aim was that partial volume effect governs the errors in volumetric dose 
quantification; while the count limitation determines the random errors. 
In this aim, we characterized the overall errors (systematic and random) of volumetric 
quantification of 90Y dose distribution from 90Y PET/CT images, which are important in 
designing clinical studies to derive the dose-response correlation derived using dose metrics 
from 90Y PET images.  Knowledge of the limitation in the dose metrics also allow 
understanding of the confidence level of the response prediction. 
Research design: 
• SA 3.1: Characterize the effects of the activity-dependent bias 
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• SA 3.2: Determine the impact of image noise (duration) and partial volume effect (PVE) 
on image-based volumetric dose quantification 
 
1.3.5.  Specific aim 4 
SA 4 : Determine the effectiveness of quiescent period gating (QPG) method for reducing 
errors in volumetric dose quantification from 90Y PET/CT images. 
90Y-PET acquisition duration can be up to 30 min/bed, during which, the PET data 
acquired are degraded by motion blur due to time-averaging of multiple breathing cycles 
(typically 4 s/cycle).  Although motion correction has been subject to active research in 18F-
PET/CT imaging (41–44), effect of motion blur on volumetric 90Y dose distribution and 
motion compensation strategies in 90Y PET/CT imaging have not been evaluated. 
Most widely used motion correction technique is gating-based PET/CT acquisition 
at quiescent respiratory period (45).  Quiescent period gating (QPG) method–both phased 
and amplitude-based methods–group the acquired data into smaller bins to minimize the 
spatiotemporal mismatch in the data due to the respiratory cycles (46).  Each bin will have 
reduced systematic errors due motion blur, but each data will have lower counts.  As a result, 
gating-based technique trades off systematic errors due to motion blur with both systematic 
and random errors due to lower signal used to reconstruct the gated PET images.  In contrast 
to 18FDG PET/CT imaging, where the acquisition duration is usually 3 min/bed, in 90Y-
PET/CT imaging with duration of 30 min/bed, it is practically not possible to increase the 
duration to compensate for the count loss. 
The objective of this aim was to determine if motion compensation using QPG is 
effective at reducing the overall errors in quantification of volumetric 90Y dose distribution 
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using dose volume histogram calculated from 90Y PET images.  Our working hypothesis was 
that tumor with relative motion range < 1 does not benefit from QPG motion compensation 
because the overall errors in the DVH’ calculated from the compensated 90Y images are not 
reduced by the motion compensation. 
In this aim, we characterized the impact of both low count, and motion blur, and the 
effectiveness of their trade-off using QPG on quantification of volumetric 90Y dose 
distribution (DVH’).  We found that QPG motion compensation did not always reduce the 
overall errors in DVH’; therefore this work is important because it allows identification of 
90Y PET/CT imaging condition where the volumetric tumor dosimetry can benefit from QPG 
motion compensation. 
Research design 
• SA 4.1: Evaluate the impact of increase image noise (due to gating) on AC 
quantification 
• SA 4.2: Evaluate the impact of motion on activity distribution quantification 
• SA 4.3: Determine the effectiveness of QPG method in improving AC quantification 
in 90Y PET/CT  images suffering from motion blur 
 
1.4.  Significance and Innovation 
1.4.1.  Significance 
In the specific aim 1 of this dissertation project, we have developed a practical 
method, using commercially available SPECT/CT systems, to reconstruct bSPECT/CT 
images with improved image quality and improved activity quantification.  Although the 
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quantitative accuracy of our bSPECT/CT images is very limited by partial volume effect (due 
to sub-optimal collimator design), the background compensated and attenuation corrected 
bSPECT images can be used to accurately quantify the total 90Y activity delivered to the 
patient, which allow gross treatment delivery verification and limited outcome prediction. 
Recent 90Y-PET-based dose-response studies (22, 23) have not been able to show a 
consistent and statistically significant relationship between dose metrics (D70 and/or Dmean) 
and tumor response, partly because the accuracy and variability in the dose metrics are 
largely unknown.  In specific aim 2–4, we characterized the accuracy and variability of 
volumetric 90Y dosimetry calculated from count-limited 90Y-PET/CT images. Knowledge of 
overall errors (systematic and random) in volumetric 90Y dosimetry is significant because it 
is the first step in a continuum of research that is expected to derive statistically significant 
dose-response model, which in turn allowing prediction of treatment outcome and 
personalization of treatment strategy. 
In addition, it has been suggested that the dose-response model can be improved by 
incorporating radiobiological models, which require information of 3D dose distribution.  3D 
90Y dose maps calculated from 90Y-PET/CT images are subject to image degrading factors 
that affect the 90Y-PET/CT images.  In addition to characterizing the overall errors, in 
specific aim 2–4, we also improved the estimated 90Y dose map by optimizing the image 
reconstruction protocol and compensating motion blur. 
     
1.4.2.  Innovation 
The innovation of bSPECT/CT imaging in specific aim 1 is that we developed an 
empirical background compensation based on adaptation of energy-window based scatter 
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estimation.  The proposed reconstruction method is very practical that it does not need any 
advance techniques such as Monte-Carlo simulation based reconstruction, which is not 
widely available for clinical use. 
Methods to generate dose map from 90Y PET/CT images have been developed (33–
35).  The volumetric 90Ydose distribution inside the tumor margin, which is calculated from 
the dose map estimate, has been used to derive dose-response model and to predict treatment 
outcome (21–23, 47).  The quantitative reconstructions of these 90Y PET/CT images, 
however, are optimized for quantifying mean dose (24, 36–39), instead of quantifying the 90Y 
dose distribution used to generate the 90Y dose map estimate.   The innovation in specific aim 
2–4 on 90Y-PET/CT imaging is that we characterized the quantification errors (systematic 
and random) of volumetric 90Y dose distribution calculated from 90Y PET images.  The 
volumetric 90Y dose distribution was quantified using dose volume histogram estimate 
(DVH’).  In specific aim 2, we optimized 90Y PET/CT image reconstruction by minimizing 
the errors in DVH’, which was innovative because, to the best of our knowledge, there have 
not been any published works on optimizing 90Y PET/CT image reconstruction other than 
using recovery coefficient of mean activity concentration as the objective function.  In 
specific aim 3 and 4, we quantified the errors (systematic and random) in DVH’ due to count 
limitation and motion blur, respectively. 
 
1.5.  Chapters organization 
The main body of this dissertation consists of 3 chapters, each written in manuscript 
form for peer-review journal publication.  Chapter 2 addresses specific aim 1.  Chapter 3 
addresses specific aim 2 and 3.  Chapter 4 addresses specific aim 4.  The final chapter 5 
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consists of summary about the key findings in this dissertation work, study limitation and 
future work. 
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Chapter 2: Practical reconstruction protocol for quantitative 90Y bremsstrahlung 
SPECT/CT 
2.1.  Introduction 
Yttrium-90 microsphere therapies are used in the management of unresectable 
primary and metastatic liver cancers.(48, 49)  In treatment planning, the radiopharmaceutical 
macro-aggregated albumin (99mTc-MAA) is used as a surrogate for 90Y microspheres.  First, 
planar imaging is used to determine the lung shunt fraction, which is incorporated into the 
dosimetry calculation to prevent radiation pneumonitis from 90Y therapy.  Next, single-
photon emission computed tomography (SPECT)/computed tomography (CT) imaging is 
used to determine whether there is extrahepatic uptake of the 99mTc-MAA and adequate 
perfusion of the target lesions.  However, several studies have shown that the distribution of 
99mTc-MAA prior to treatment may not be a consistent and reliable indicator of the post-
treatment distribution of the 90Y-microspheres.(12, 13) These potential discrepancies in 
distribution between planning 99mTc-MAA and treatment 90Y-microspheres support the need 
for post-treatment 90Y imaging to assess treatment delivery. However, bremsstrahlung 90Y 
imaging is challenging. 
In contrast with the majority of the radionuclides used in nuclear medicine imaging, 
90Y is effectively a pure beta emitter, i.e., it lacks discrete-energy photon emissions, such as 
gamma rays and/or characteristic fluorescence X-rays. The X-ray photons emitted by 90Y are 
very low in both yield (<< 1 ppm) and energy (<< 18 keV), and the gamma photons emitted 
by 90Y have an insignificant yield (<< 1 ppm) and very high energy (~ 2 𝑀𝑒𝑉).  Yttrium-90 
activity distribution in vivo is traditionally assessed by imaging the bremsstrahlung photon, 
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which is produced from interactions of energetic beta particles with soft tissue, using planar 
and/or SPECT/CT imaging. 
Yttrium-90’s lack of photopeaks has stunted standardization of 90Y bremsstrahlung 
imaging procedures; consequently, image quality varies widely amongst different facilities. 
The 90Y decay process also has a very small branching to the excited state of stable 90Zr, 
which is followed by an internal pair production (32 ppm per β- decay).(50)  The positrons 
generate a pair of 511-keV annihilation photons that can be imaged using 90Y positron 
emission tomography (PET)/CT.  Recent studies have suggested that 90Y PET/CT imaging 
provides better image quality (contrast and resolution) and quantification than 
bremsstrahlung SPECT/CT.(24, 25)  Preliminary results of studies of tumor dosimetry, 
treatment response, and toxicity based on quantitative 90Y PET/CT and 90Y SPECT/CT post-
therapy imaging have been presented. (14, 22, 51)  However, at present, there is no well-
established standardized imaging protocol for 90Y imaging in vivo with either SPECT/CT or 
PET/CT.  
In contrast to gamma and X-ray emitter imaging, in which the object spatial information is 
carried by photons with a discrete energy, bremsstrahlung imaging’s the object spatial 
information is carried by photons with a continuous energy distribution.  In discrete energy 
photopeak imaging, the imaging energy window (EW) is defined such that it accepts most of 
the primary photon emission while rejecting most of the scatter.  The EW is usually centered 
on the photopeak and its extend (width) is governed by the energy resolution of the gamma 
camera, however the continuous nature of 90Y photon emissions prohibit such 
straightforward approach.  Simulation work (52, 53)  have shown that a typical 90Y 
bremsstrahlung emission spectrum from 90Y activity in the liver can be expressed as the sum 
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of 5 spectral components: primary bremsstrahlung, object scatter, camera backscatter, 
collimator scatter and penetration, and lead X-rays produced in the collimator.  At any given 
EW, the ratio of primary bremsstrahlung to the total number of photons detected is < 15%, 
with the highest primary fraction around 80–180 keV.(52–54)  
Research on improving 90Y bremsstrahlung imaging both qualitatively and 
quantitatively is ongoing, but most of the published solutions require some sort of Monte 
Carlo simulation.  Rong et al used Monte Carlo simulations to accurately model the energy 
dependent object attenuation, scatter and the collimator-detector response to obtain 
quantitatively accurate images(27). The net percent errors in activity estimates from physical 
geometrical phantom experiments and simulated patient data were shown to be 5-10 %.  
Elschot et al directly incorporated into the reconstruction algorithm the energy dependent 
photon scatter and attenuation estimated from Monte Carlo simulations(28). Their approach 
demonstrated higher tumor contrast and lower mean residual count in lung insert albeit at the 
cost of higher image noise.  These advanced Monte Carlo based approached are not 
commercially available and cannot be easily implemented in the routine clinical practice. The 
lack of their widespread use is further exacerbated by the fact that many 90Y procedures, at 
least in the United States, are performed in interventional radiology clinics that are often not 
associated with academic hospitals. 
The objective of this study was to develop a practical imaging protocol to improve 
90Y bremsstrahlung SPECT/CT image quality and quantification that could be readily 
implemented on commercially available imaging systems. To accomplish our objective, we 
developed a simple method for determining an appropriate imaging EW, its EW-based 
background compensation (BC), and CT-based attenuation correction (AC). Furthermore, we 
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present approaches for the optimization of SPECT reconstruction parameters for both 
detection and quantification.  Finally, we address the implementation and accuracy of self-
calibration that lead to total activity quantification from 90Y SPECT/CT images. 
 
2.2.  Methods 
All data acquisition and analysis were performed on Symbia TruePoint SPECT/CT 
systems (Siemens Medical Solutions, Hoffman Estates, IL, USA). 
2.2.1. Defining energy windows for CT attenuation correction 
Six preliminary EWs (the maximum allowed on the SymbiaTruePoint SPECT/CT 
systems) were defined in order to separate the total 90Y bremsstrahlung spectrum into regions 
dominated by different spectral components: 70–100 keV (object scatter and lead X-rays), 
100–125 keV (object scatter), 125–175 keV (backscatter), 175–225 keV (backscatter), 225–
300 keV (backscatter, collimator scatter and septal penetration), and 300–400 keV 
(collimator scatter and septal penetration).  The maximum widths of the EWs were 
constrained by the ability to accurately represent photon attenuation at the mean energy of 
each window to facilitate SPECT AC, such that, if Δµ is the difference in linear attenuation, 
µ, between the extreme energies of a window, we required Δµ/µmean < 10%. The 10% limit 
on Δµ was based on earlier work that showed that SPECT images were accurate to within 1% 
when Δµ/µmean< 6%.(55) 
The electron density phantom we used (model 062, CIRS, Norfolk, VA) enables 
precise correlation of CT data in Hounsfield units (HU) to the linear attenuation coefficient, 
µ (cm-1). It includes 8 different reference tissues with CT values ranging from −790 HU 
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(lung inhale) to 235 HU (trabecular bone). An axial CT scan of the electron density phantom 
was performed at a high tube current to minimize CT noise (130 kVp, 200 mAs). The CT 
image was converted into µ-maps using proprietary software (e.Soft, Siemens Medical 
Solutions) that converted each CT image into a μ-map at a user-defined emission energy at 5 
keV intervals from 70–511 keV (the range is limited by the software). Circular regions of 
interest (ROIs) were drawn within the inserts to calculate their µ as a function of photon 
energy. 
Starting with the above-defined 6 EWs, we iterated on the EW widths so that the 
Δµ/µmean was < 10% in each EW for the adipose, soft tissue, muscle, and liver inserts.  
Considerations were also made to isolate the various scatter components in different EWs. 
 
2.2.2. Choosing appropriate imaging energy windows 
In this work, the primary signal was assumed to be spatially registered within the 
object, while the background signal was considered to be more widely distributed across the 
image. It is important to note that this primary signal definition may contain object scatter in 
addition to the primary bremsstrahlung and perhaps even some smaller contributions from 
collimator scatter, septal penetration, and backscatter. We defined the imaging EW as the 
EW that had the highest fraction of primary signal to background signal.  
Fig 1 shows the phantom experiment setup, which acquired using a gamma camera 
with 1.6-cm (5/8-inch) crystal.   Yttrium-90 (III) chloride solution was placed in a vial (8.5 
cm × 3.3 cm) 1 cm.  The 90Y phantom was positioned at 30 cm above the gamma camera 
with a medium-energy low-penetration (MELP) collimator.  Acrylic slabs of various 
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thicknesses (2, 5, 9, 12, and 16 cm) were placed right below the phantom to introduce 
attenuation and scatter.  For the 5 cm-thick acrylic slab, the distance between the collimator 
and the phantom was varied to 15, 20, 25, 30, and 35 cm.  Planar static images were acquired 
for each imaging condition.  Each static image was acquired in the 6 EWs determined in Sec. 
2.A.  For each imaging condition, planar images with 2 million counts were acquired in the 
90–125 keV EW. 
 
Fig 1. The experimental setup used to acquire 90Y planar images under different imaging 
conditions.  Both the acrylic thickness and the distance between the collimator and the 
phantom were varied. 
To calculate the signal-to-background ratio, we drew 2 ROIs on each of the static 
images (Fig 2):  a small ROI at the center, enclosing the image of the object, and a larger 
ROI that enclosed the entire field of view (FOV).  The total counts in the small ROI 
represented the numbers of photons carrying more object spatial information. This was 
designated as the primary signal.  The total counts in the periphery, calculated by subtracting 
the total counts in the smaller ROI from those in the larger ROI, represented the number of 
scattered photons that had already lost their spatial information. This was designated as the 
background signal. 
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For each EW, the mean pixel count per keV was calculated by dividing the total 
counts from the ROIs by the EW width and the number of pixels in the ROI.  Signal-to-
background ratio was calculated as the mean pixel count/keV in the center divided by the 
mean pixel counts/keV in the periphery.  The signal-to-background ratios were calculated for 
all static phantom images (all 6 EWs for all imaging conditions).  The EW with the highest 
signal-to-background ratio was used as the imaging EW. 
  
Fig 2. The larger ROI (periphery), indicated in red, encloses the entire FOV of the 
gamma camera.  The smaller ROI (center), indicated in blue, encloses the projected 
image of the phantom.  The background counts in the periphery region were calculated 
by subtracting the counts for the small ROI from those of the large ROI.  The small ROI 
contains both the primary signal counts, which carry more object spatial information, and 
unwanted background counts. 
 
2.2.3. Developing empirical energy window-based background compensation for 90Y 
bremsstrahlung imaging  
Our empirical EW-based BC model adapted the EW-based scatter correction model, 
in which the scatter in the imaging EW is estimated as a scaled image of the scatter-estimate 
EW.(56–58)  In this work, we used scaled images of the BC EW as a model to compensate 
for the background signal in the imaging EW.  The BC EW was selected empirically from 
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our phantom study and based on the errors in the activity recovery coefficient and the amount 
of residual background count in the cold lung insert.  The scaling coefficients were calculated 
from clinical images.  The use of a single scaling coefficient for BC can be justified if low 
variation in the scaling coefficients is observed under clinical imaging conditions.  We used 
clinical planar images (anterior and posterior views) of 10 post-90Y-microsphere therapy 
patients with inherent random geometries (patient thicknesses and distance to collimator).  
The images were acquired using a Symbia T gamma camera with a crystal thickness of 
1.6 cm.  For each potential BC EW (5 EWs: A, C, D, E, and F), the scaling coefficients were 
derived by averaging the scaling coefficients calculated for each clinical planar image of the 
10 patient scans, for 20 images in total.  The scaling coefficients were calculated as the ratio 
of the periphery ROI total counts in the imaging to the potential BC EWs (Fig 3).  The 
variations in the scaling coefficients for each potential BC EW in the clinical scans were 
reported as 1 standard deviation. 
 
Fig 3.  Clinical planar images in imaging (A) and potential background compensation (B) 
energy windows showing the positioning of regions of interest (outside but adjacent to 
the liver) from which the total counts were extracted to calculate the scaling coefficient 
for the empirical background compensation model.  The area superior to the liver was 
excluded to avoid including any signal contamination from the lung shunt. 
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The most appropriate BC EW was determined empirically according to 2 criteria: 1) 
the maximum recovery coefficient of the 37-mm sphere and 2) the minimum residual activity 
concentration in the cold lung insert of a NEMA IEC body phantom (Biodex, Shirley, NY).  
The phantom was filled with 2.8 GBq (75.4 mCi) 90YCl3 with the sphere-to-background ratio 
of 7.8.  SPECT/CT images of the phantom were acquired for 28 s/view for 2 × 64 views over 
360° using Symbia T6 SPECT/CT systems with 1.6 cm NaI(Tl) detectors and MELP 
collimators.  The acquisition EWs were chosen based on the results reported in Sec. 3.B.   
SPECT/CT images of the IEC phantom were reconstructed using the Ordered 
Subset Expectation Maximization (OSEM) (Flash 3D, Siemens Medical Solutions) algorithm 
with CT attenuation (See Sec. 2.A) and 5 different BC models.  The number of equivalent 
iterations (subset × iteration) was 8 × 8 (based on results reported in Sec. 3.E).  The 
reconstructed images had a matrix size of 128 × 128 and a voxel size of 4.8 mm.  No post-
reconstruction filter was applied to the images to avoid further image resolution degradation 
on inherently poor-resolution bremsstrahlung 90Y images. 
For each reconstructed image set, a spherical volume of interest (VOI) with a 
diameter of 10 mm was placed inside the 37-mm sphere, and cylindrical VOIs with diameters 
and lengths of 25 mm were placed in the adjacent background and in the lung insert. A VOI 
of 10 mm in diameter for the 37-mm sphere was chosen to decrease the partial volume effect.  
Observed sphere-to-background ratio recovery was calculated from the mean counts inside 
these VOIs, i.e., meansphere/meanbackground.  Residual activity concentration in the lung insert 
was calculated as a fraction of mean count in the background, i.e., meaninsert /meanbackground.  
The most suitable BC model was determined based on the recovery of the true sphere-to-
background ratio (measured/true) and the residual mean count in the lung insert. 
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The improvement in image contrast after BC was evaluated visually and semi-
quantitatively by comparing the contrast-to-noise ratio (CNR) of the lesions before and after 
the BC was applied.   The CNRs of the lesions were calculated as CNR = meanlesion−meanbackground
�meanbackground
; where meanlesion and meanbackground are mean ROI counts in 
the hot lesions and warm liver, respectively.   
 
2.2.4. SPECT/CT activity calibration for quantification 
The SPECT calibration factor was defined as the ratio of the total activity in the 
FOV to the total counts in the FOV.  For ideal image reconstruction (with accurate 
corrections for scatter, attenuation, and collimator-detector response), calibration with a point 
source in air suffices. In practice, however, the image reconstruction is not ideal, so the 
calibration factor is usually derived from phantom images with all the necessary corrections 
applied.  It is imperative that the calibration of the SPECT/CT imaging system remain valid 
under clinically relevant conditions to minimize the variations in activity quantification that 
may result from a mismatch between the calibration and clinical imaging conditions. 
Post-therapy 90Y SPECT/CT scanning presents a unique condition in which the total 
90Y activity inside the liver (and hence inside the SPECT FOV) can be determined with 
uncertainty < 10%.  Clinical images acquired under such conditions can be used to calibrate 
the SPECT/CT imaging system.  In this study, the calibration factors were calculated from 30 
post-90Y-microsphere therapy SPECT/CT studies with a wide range of abdomen sizes, from 
19–40 cm (measured in the anterior-posterior direction from the transaxial CT images).  The 
patient scans were chosen such that the net administered activity could be determined with 
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high accuracy. Activity uncertainty in the FOV was maintained at < 7% by selecting patient 
scans with a lung shunt fraction < 5% and administered activity residuals ≤ 2% and by 
assuming the error in dose calibrator assay ≤ 3%. 
All clinical images were acquired using gamma cameras with a crystal thickness of 
1.6 cm in the EWs described in Secs. 2.A and 2.B.  The planar images were acquired for 
10 min with a matrix size of 256 × 256 and pixel size of 2.4 mm.  The SPECT projection 
images were acquired for 28 s/view for 2 × 64 views over 360°.  The SPECT images were 
reconstructed using the OSEM algorithm with number of equivalent iterations of 64, 
(optimized in Sec. 2.E), matrix size of 128 × 128, voxel size of 4.8 mm, and post-
reconstruction Gaussian filter of 4.8 mm. 
The calibration factors were calculated for the following image types: planar 
images, SPECT images with no correction (SPECT only), SPECT images with CT-based AC 
(Sec. 2.A) (SPECT with AC), and SPECT images with both CT-AC (Sec. 2.A) and BC (Sec. 
2.C) (SPECT with AC+BC).  For each image type, we used linear regression analysis to 
derive the relationship between the total injected activity in the FOV and the corresponding 
total count rates (total counts/frame duration) in the same image FOV.  The global calibration 
factor and its uncertainty were calculated from the regression equation as the gradient and its 
standard error.  The validity of using a single global calibration factor under various clinical 
imaging conditions was evaluated based on the standard deviation of the residuals (the 
difference between the actual activities with the predicted injected activities with respect to 
the actual values) in the linear regression analysis. 
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2.2.5. Reconstruction-parameter optimization for qualitative and quantitative 
SPECT/CT images 
The IEC phantom data acquired in Sec. 2.C were also used for this section.  The 
SPECT/CT images were reconstructed using the 3D-OSEM (Flash 3D) algorithm with CT 
attenuation (Sec. 2.A) and a final empirical BC model (Sec. 3.C).  We varied the number of 
equivalent iterations(59) from 8 to 256: 8 subsets with 1–16 iterations and 16 subsets with 
12–16 iterations.  The reconstructed images had a matrix size of 128 × 128 and a voxel size 
of 4.8 mm.  No post-reconstruction filter was applied to the images.  For each total number of 
iterations, the SPECT/CT count-to-activity calibration factor was calculated as the total 
injected 90Y activity divided by the total counts in the entire reconstructed volume.  Self-
calibration of the respective SPECT/CT images was performed for absolute image 
quantification, i.e., voxel unit in Bq/mL. 
Spatial resolution (partial volume effect) and convergence of iterative 
reconstruction both affect the SPECT quantitative accuracy. For each reconstructed image, a 
spherical VOI with a diameter of 10 mm was placed inside the 37-mm sphere, and cylindrical 
VOIs with a diameter and length of 25 mm were placed in the adjacent background and in 
the lung insert.  VOI of 10 mm in diameter for 37-mm sphere was used to minimize the 
partial volume effect.  Measured sphere-to-background ratios were calculated from the mean 
counts inside these VOIs (meansphere/meanbackground).  The total number of iterations was 
optimized based on the recovery of the true SBR, i.e., SBRmeasured/SBRtrue.  The activity 
quantification accuracy was measured as the activity recoveries in the 37-mm sphere and in 
the background, i.e., measured activity/true activity.  The efficacy of the EW BC was also 
evaluated by measuring the relative activity in the lung insert with respect to the background 
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activity.  In addition, the activity quantifications in the 37-mm sphere and in the background 
using SPECT with CT AC+BC were also compared with the activity quantification in 
SPECT with AC. 
 
2.3. Results 
2.3.1. Defining energy windows for CT attenuation correction 
Table 1 shows the 6 energy windows (EW A–B) that maintained Δµ/µmean < 10% 
for each of the 4 materials considered. The Elow and Ehigh limits were very similar for all 4 
materials. The average Elow and Ehigh values are shown in the column of Table 1 labeled 
“AverageCT-AC”.  When considering BC, it is best to define the EWs such that the various 
spectral components are isolated in different EWs (e.g., the dual-EW technique uses 1 
window for photopeak + scatter and a second window for scatter only).  Since individual 
separation of 5 spectral components of bremsstrahlung is not possible because of its 
continuous nature, we adjusted the AverageCT-AC windows to maximize separation between 
the various spectral components. These EW definitions are labeled “NominalAC,SC” and were 
selected as the acquisition EWs in this experiment.  Based on the energy and spatial 
distribute`on analyses, EW B (90–125 keV) was determined to be the primary imaging 
window. 
 
Adipose Soft Tissue Muscle Liver AverageCT-AC NominalAC,BC 
CT # −63.6 −4.4 40.1 48.7 n/a n/a 
A 70–90 70–90 70–90 70–90 70–90 70–90 
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B 90–130 90–125 90–125 90–125 90–126 90–125 
C 130–175 125–180 125–170 125–170 126–174 125–160 
D 175–235 180–245 170–230 170–230 174–235 160–215 
E 235– 310 245–320 230–305 230–300 235–309 250–310 
F 310–400 320–420 305–410 300–400 309–408 310–410 
Table 1. The low and high photon energy limits of the 6 energy windows for < 10% change 
in the attenuation coefficient (AverageCT-AC) for adipose, soft tissue, muscle, and liver, and 
modified for energy window-based background compensation (NominalAC,BC).  CT numbers 
are in HU units and energy windows A–F are in keV. 
 
2.3.2. Choosing an appropriate imaging energy window 
The calculated SBRs from the images acquired under different imaging conditions 
(scattering material thickness of 2−16 cm at 30 cm away from the MELP collimator and 
scattering material thickness of 4.8 cm at 15–35 cm away from the MELP collimator) 
exhibited similar patterns, i.e., the sphere-to-background ratio was the highest in EW B 
(~8.53), as shown in Fig 4. 
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Fig 4. The signal-to-background ratios (SBR) of 6 energy windows (EWs) for the tested 
attenuating material thicknesses and source-to-collimator distance combinations, 
indicated by different bar colors. EWs A, B, and C had high signal-to-background ratios, 
i.e., they contained relatively high spatial information, whereas EWs E and F had low 
signal-to-background ratios, i.e., they contained relatively low spatial information.  The 
means and standard deviations (stdev) of the SBRs for the EWs are shown in the adjacent 
table. 
 
2.3.3. Developing empirical energy window-based background compensation for 90Y 
bremsstrahlung imaging 
The mean scaling coefficients ± 1 standard deviation for each BC model were 0.92 
± 0.04, 0.91 ± 0.05, 0.55 ± 0.05, 0.75 ± 0.09, 0.53 ± 0.07 for EWs A, C, D, E, and F, 
respectively.  The coefficient of variance of the scaling coefficients was ~10%, which 
suggests that a fixed scaling coefficient factor may be implemented for BC in clinical 
images. 
mean stdev
A 8.13 17%
B 8.53 17%
C 6.65 13%
D 4.50 9%
E 3.41 8%
F 2.97 12%
SBR
EW
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Using EW F for BC in SPECT/CT image reconstruction of the IEC phantom 
fulfilled both criteria: maximum SBR recovery and minimum lung insert residual activity; 
therefore, the EW-based BC for imaging EW B can be modeled as EW B − 0.53 × EW F.  
Using this model, the SBR recovery coefficient for the 37-mm sphere of the IEC phantom 
was the highest at 87%, and the lung insert residual activity was the lowest at 14%, as shown 
in Fig 5.   
 
Fig 5.  Recovery coefficients for 37-mm sphere and lung insert residual in the IEC phantom 
for SPECT/CT images reconstructed without background compensation and with 5 models of 
background compensation. 
Fig 6 shows clinical examples of background-compensated planar images from 4 
different patients.   The BC improved the image contrast of the planar images.  The tumors’ 
detectability as measured by CNRs (shown beside selected tumors in Fig 4 increased after the 
application of the proposed BC. While the edges of the images still look fuzzy because of the 
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inherently poor resolution of 90Y, whose maximum beta range is 11 mm in water, improved 
delineation of the liver and liver lobes is apparent.   
 
Fig 6.  The uncorrected and background-compensated clinical images demonstrating that the 
energy window-based background correction improves the visualization of the liver and 
lesions.  All images are shown using the same window width and level. The background-
corrected images show improvement in the contrast-to-noise ratios of the lesions (inset 
numbers), which corresponds to improved visibility. The corrected images also exhibit 
improved liver and tumor delineation. 
 
2.3.4.  SPECT/CT activity calibration for quantification 
For various reconstructed SPECT and planar images, the global calibration factors 
(gradients), their uncertainties (standard errors of the gradients), and the coefficients of 
determination (R2) of the regression lines are presented in Table 2.  In all cases, the total 
counts observed were proportional to the 90Y activity in the FOV with R2 > 0.9.  As expected, 
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the variations in the calibration factors exhibited the lowest variation in SPECT with AC + 
SC and the highest in SPECT-only and planar images. 
 The activity residual in EW B after linear regression is plotted in Fig 7; the 
standard deviations of the activity residuals were 11.3%, 5.6%, 5.2%, and 9.1% for SPECT 
only, SPECT with AC, SPECT with AC + SC, and planar images, respectively.  Activity 
predictions using SPECT with AC and SPECT with AC + SC had lower variation than did 
predictions made using SPECT-only or planar images.  The predicted activity in an IEC 
phantom using the global calibration factor derived from clinical scans introduced an error of 
−25% with respect to the true injected activity. 
Image Type R2 CF (Bq/cps) 
 
Std. Error (%) 
SPECT 0.901 7.5 6.9% 
SPECT AC 0.972 2.3 4.0% 
SPECT AC + BC 0.982 4.0 2.8% 
Planar 0.917 417.5 5.7% 
Table 2.  Results of the linear regression analysis of the relationship between total activity in 
the field of view and the corresponding total counts in the images.  AC: attenuation 
correction, BC: background compensation, CF: calibration factor. 
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Fig 7.  The activity residuals, defined as the difference between the true and predicted values 
relative to the true value, in EW B (90–125 keV) after linear regression.  (A) Variations from 
SPECT/CT images with attenuation correction and background compensation. The mean and 
the maximum of the absolute deviation were 4% and 10%, respectively.  The red square 
indicates the data point from the IEC phantom with a sphere-to-background ratio of 8. (B)  
Variations from SPECT/CT images with attenuation correction only.  The mean and the 
maximum of the absolute deviation were 4.5% and 12%.  (C) Variations from uncorrected 
SPECT images.  The mean and the maximum of the absolute deviation were 9% and 27%, 
respectively.  (D)  Variations from total counts in opposing planar views.  The mean and the 
maximum of the absolute deviation were 10% and 23%, respectively. SD: standard 
deviation. 
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2.3.5. Reconstruction-parameter optimization for qualitative and quantitative 
SPECT/CT images 
2.3.5.1.  Quantitative SPECT/CT imaging 
The activity concentration and SBR recovery of the 37-mm sphere and the activity 
recovery in the background region in SPECT/CT images of the IEC phantom with CT AC + 
BC are shown in Fig 8.  The background activity concentration converged rapidly (after 16 
iterations), while the 37-mm sphere activity converged more slowly (after 128 iterations).  
The activity concentration in the background was fully recovered (~100%) at convergence 
and the activity concentration in the 37-mm sphere was partially recovered (90%) at 
convergence.  The SBR recovery (87%) converged after 128 iterations as well.  The 
measured activity concentration in the cold lung insert was calculated with respect to the 
background activity.  The activity concentration in the cold lung insert vanished slowly as a 
function of total number of iterations.  At 128 iterations, the activity concentration in the lung 
inserts was 14% of the activity concentration in the background. 
As a comparison, at 128 iterations, the SPECT/CT images of the IEC phantom 
reconstructed using CT AC only had recovery of 39%, 82%, 48%, and 44% for the sphere, 
background, SBR, and lung insert, respectively. 
The proposed BC method increased the activity concentration in the sphere and the 
SBR recovery by more than 2-fold (from 39% to 90%).  The false-positive activity in the 
cold lung insert fell from 44% to 14%. 
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 Fig 8.  Recovery coefficients as a function of the total number of iterations.  The 
background activity concentration reached 100% recovery rapidly (after 16 number of 
equivalent iterations).  The activity concentration in the 37-mm spheres (using a 
10mm-diameter VOI to minimize the partial volume effect) reached a plateau after 
128 equivalent iterations (90% recovery).  After 128 equivalent iterations, the signal-
to-background ratio recovery also reached a plateau.  The measured activity 
concentration in the cold lung insert was calculated with respect to the background 
activity.  At 128 iterations, the activity concentration in the lung insert was 14% of 
the activity concentration in the background.  The error bars indicate standard 
deviations for the volumes of interest. SUB: subset, IT: iteration. 
 
2.3.5.2.  Qualitative SPECT/CT images 
As the number of equivalent iterations increased, the recovery of the activity in the 
sphere also increased.  For OSEM reconstruction, however, the background noise also 
increased as a function of the number of equivalent iterations, as demonstrated by the 
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growing error bars in Fig 8 as a function of the number of equivalent iterations.  Fig 9 shows 
the 37-mm sphere detectability (measured as CNR) as a function of the number of equivalent 
iterations.  The highest CNR, 25, was achieved at 16–24 number of equivalent iterations 
before the sphere activity concentration converged.  At convergence (64 iterations), the CNR 
had decreased to 18 for SPECT with AC + SC and 13 for SPECT with AC.  Visually, more 
spheres were detectable at lower iterations [Fig 9 (a)] than at higher iterations at convergence 
[Fig 9(b)].  SPECT with AC [Fig 9 (c)] had lower detectability than did SPECT with AC + 
BC. 
 
 
Fig 9.  (left) Detectability (contrast-to-noise ratio, CNR) of the 37-mm sphere as a 
function of the number of equivalent iterations in SPECT/CT images with CT 
attenuation and background compensation (solid blue line).  The red square indicates 
the CNR of the sphere for SPECT/CT images with CT attenuation correction only at 
convergence. (right) Transaxial and coronal images of the IEC phantom: (a) 
attenuation-corrected and background-compensated at the highest CNR (37-mm 
sphere), (b) attenuation-corrected and background-compensated at convergence (37-
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mm sphere), and (c) attenuation-corrected at convergence.  Attenuation correction 
and background compensation improved detectability [(b) versus (c)].  The highest 
detectability was achieved before convergence [(a) versus (b)].  In (b), the SBR was 
about 7, whereas the SBR in (c) was only about 3. SUB: subset, IT: iteration 
 
2.4. Discussion 
2.4.1. Limitation of the proposed background-compensation method 
The proposed BC method is an empirical model. Monte Carlo simulation studies are 
required to accurately correct for specific components of scatter in the imaging EW. For 
example, Monte Carlo simulation studies[11,12] suggest that EW F (315–415 keV) may 
contain little or no object scatter information.  Although our proposed BC method was not 
designed to correct for any specific source of contamination in the imaging EW B (e.g., 
object scatter, septal penetration, septal scatter, backscatter), we have shown that the 
proposed method increased both the CNR (detectability) and the accuracy of activity 
quantification. 
The BC factor was derived for a Siemens Symbia T gamma camera with a 1.6-cm 
crystal and MELP collimator.  Since energy window-based scatter correction is dependent on 
the energy spectrum, other makes and models of cameras with different crystal thicknesses 
and collimators will likely require different BC parameters, i.e., EW selections and BC 
scaling factors.  The methodology described here, however, could be applied to develop BC 
models for 90Y bremsstrahlung SPECT/CT imaging using other SPECT/CT systems.  The 
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readers are encouraged to use the procedure outlined here to determine the BC factors on 
their own systems prior to the clinical implementation of this technique. 
 
2.4.2.  Energy window selection 
The signal-to-background ratio the highest in EWs A and B (and perhaps even C), 
which means that these EWs provided more spatial information in the image than did the 
other EWs.  This finding is consistent with other studies that found that the optimal EW for 
qualitative 90Y bremsstrahlung imaging was 80–180 keV.(54, 60)  However, EW A was 
contaminated by the characteristic X-rays (70–90 keV) from the lead collimator and lead 
housing, so we chose EW B (the EW with the highest SBR) as the imaging EW of the 90Y 
bremsstrahlung images. 
However, the BC EW was chosen empirically based on the SBR recovery, as shown 
in Fig 5.  Since EWs A and C had signal-to-background ratios comparable to that of EW B—
that is, they contained good spatial information—using these EWs to compensate for 
background yielded a decrease in SBR recovery compared to using no BC. 
To further validate our empirical method, two line profiles were extracted from the 
static images in EW B and EW F (Fig 10).  One line profile was extracted across an image of 
a liver and the other one was drawn in the background region.  The line profiles of the liver 
images showed that EW B provided much more spatial information of the liver image than 
did EW F.  The line profiles in the background region suggest that the spatial distributions of 
the background signal were similar in EW B and EW F, supporting the usefulness of the 
proposed BC mode to compensate for the background signal.  
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Fig 10. The images on the top are clinical images from Fig 6 in energy window (EW) B 
(left) and F (right) showing the locations from which the line profiles were extracted.  
The graphs at the bottom show line profiles in EWs B and F (scaled) across the liver 
image (left graph) and line profiles of EWs B and F (scaled) across the background 
region outside the liver (right graph).  In the regions outside the liver (shaded), the 
background profiles in EWs B and F (scaled) are indistinguishable. 
 
2.4.3.  Partial volume effect and bremsstrahlung 90Y quantitative accuracy 
Yttrium-90 bremsstrahlung imaging using current commercially available gamma 
camera is hardware limited.  The collimators used for nuclear medicine imaging are not 
designed for such high energy (up to 2.3 MeV) bremsstrahlung photon spectra of 90Y.  The 
observed events in the gamma camera have high contaminations from photons that have 
undergone septal penetration, septal scatter and backscatter that contribute to low image 
contrast.  Furthermore, bremsstrahlung imaging has an inherent poor resolution due to 
electron staggering (up to 11 mm in soft tissue) in the bremsstrahlung production.  These 
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limitations may be addressed by optimizing(61, 62) the gamma camera collimator design for 
90Y bremsstrahlung imaging and by incorporating the physics model of electron staggering 
and bremsstrahlung photon generation in 90Y SPECT/CT reconstruction using Monte Carlo 
simulation(27, 28, 63).   
In order to minimize the interplay of the partial volume effect when assessing 
SPECT convergence, we used a VOI with 10-mm diameter to assess the recovery of activity 
concentration for the 37-mm sphere.  As a result, up to 90% of the activity concentration in 
the 37-mm sphere was recovered at convergence.  Qualitatively, as seen in Fig 9, spheres 
with diameter below 22 mm were not clearly visible in reconstructed 90Y SPECT/CT images.  
As shown in Fig 11, the closer the VOI diameter is to the nominal diameter of the 37-mm 
sphere, the lower the recovery coefficient.  Due to the partial volume effect, when using a 
VOI that matches the 37-mm sphere size, the recovery coefficient of 55% was realized.  
However, matched VOIs between CT and SPECT are needed for tumor dosimetry. 
Therefore, use of various published techniques to compensate for the partial volume effect 
will need to be employed for tumor dosimetry in clinical practice(64, 65).  In contrast, the 
partial volume effect in 90Y PET/CT is less pronounced.  Recent 90Y PET/CT quantitative 
studies(66, 67) have suggested that the recovery coefficient of 90% is achievable in a 37-mm 
sphere using a matching VOI size. 
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 Fig 11. Graph of signal-to-background ratio recovery as a function of the diameter of the 
volume of interest (VOI).  The SBR recovery decreases as the VOI diameter increases, 
demonstrating the partial volume effect. 
 
2.4.4.  Count-to-activity calibration factor derivation 
The unique imaging conditions of 90Y microsphere therapy permit SPECT/CT 
counts-to-activity calibration for generating quantitative 90Y SPECT/CT images to be 
performed using clinical 90Y images. SPECT images with CT AC + BC can be used to 
accurately quantify the activity present in the FOV with a mean absolute deviation ≤ 4%.  
Because the calibration factor determined using the IEC phantom demonstrated a substantial 
bias, caution is warranted when using an IEC phantom to calibrate SPECT/CT systems, since 
it may not accurately represent clinical imaging conditions in terms of attenuation and 
scatter. 
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2.4.5.  Reconstruction parameter optimization 
For OSEM reconstruction, the background noise also increases as a function of the 
number of equivalent iterations (Fig 8); therefore, the highest detectability (as measured by 
CNR) is usually achieved before the convergence (Fig 11).  At convergence, even though the 
image quantification is more accurate, image detectability may actually be lower. 
 
2.4.6.  Correction for deadtime count loss 
Because the yield of bremsstrahlung radiation in adipose and soft tissue (low-Z 
material) with a high energy spectrum is low, the number of detected photons is low; hence, 
gamma camera deadtime count loss is not an issue for post-therapy 90Y SPECT/CT imaging.  
The number of total counts per activity was found to be linear (at least in the activity range of 
1–5 GBq), providing further confirmation that the gamma camera does not suffer from 
deadtime count loss.  If, however, correction for deadtime count loss is needed, the recently 
proposed revised monitor source method for practical deadtime count loss compensation can 
be employed. (68, 69) 
2.5. Conclusion 
We have proposed a practical method to reconstruct quantitative SPECT images 
with CT attenuation correction and empirical EW-based BC.  For Siemens SymbiaT 
SPECT/CT systems, we found that EW B (90–130 keV) and EW F (310–400 keV) are the 
most appropriate to be used as the imaging and BC EWs.  Despite our empirical correction 
method’s limitations, our phantom study shows that our reconstruction and compensation 
method improves both image quality and quantification. 
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Chapter 3: Quantitative 90Y-PET image reconstruction: optimization 
3.1. Introduction 
90Y microspheres have been used for treating non-resectable liver cancer (48, 49).  
Current dosimetry standard for 90Y-microspheres treatment planning, as recommended by 
AAPM (70) is the schema (71) developed by MIRD dosimetry that assumes uniform 
distribution in normal liver, tumor, and lung using partition mode (72) based on the surrogate 
99mTc-MAA planar images.  This simplistic model aims to calculate the mean organ absorbed 
dose for safe treatment planning (73). 
In diagnosis nuclear medicine imaging, mean organ absorbed dose is the primary 
dosimetry metric of interest to evaluate population cancer risk from the imaging procedure.  
On the other hand, in (pre and post) therapy imaging, the dosimetry task aims to calculate 
normal tissue complication probability (NTCP) and tumor control probability (TCP) for the 
individual patient.  These two RPT end points require the dose distribution information, 
which is beyond mean absorbed dose (40, 74); therefore there is a pressing need for 
volumetric dosimetry of 90Y. 
In the past decade, volumetric 90Y dosimetry techniques have been implemented 
based on 3D 90Y-activity distribution from both bremsstrahlung SPECT/CT (20, 51) and 
more recently from PET/CT (21, 35, 75) imaging.  It has also been shown that local 
deposition method can be used to generate 90Y dose map (Gy) by scaling the PET images 
(Bq/mL) using a single conversion factor (Gy/Bq/mL) (22, 35, 51).  Since 90Y PET/CT 
images have been suggested to have advantages over bremsstrahlung SPECT/CT in term of 
image contrast, resolution, and hence quantification ((24–26), in this work, we focus on 90Y 
PET/CT to quantify volumetric 90Y dose. 
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3D activity distribution that is observed in emission images is subject to image 
degrading factors such as partial volume effect, image noise, and motion blur (40).  
Consequently, the dose volume histogram calculated from these images (DVH’) suffers from 
errors due to these degrading factors.  While these degrading factors affect all nuclear 
medicine imaging, 90Y PET imaging presents a unique challenge in that it has an extremely 
low signal, coming from 32 ppm of positron yield produced via internal pair production.   
Several groups have used DVH’  to summarize the information of 3D dose 
distribution estimated from 90Y PET images (22, 23, 25).  DVH (76) plots in the abscissa the 
minimum dose (Dx) that covers x% of the volume of interests (VOI) in the ordinate.  The 
spread of the DVH curve around the median indicates the non-uniformity of the 3D dose 
distribution in the VOI (77).  The two aforementioned RPT end points, i.e., TCP and NTCP 
can be calculated from DVH (78, 79).  In practice, however, calculation of TCP and NTCP 
are complicated as they require radiobiological parameters that are difficult to determine 
from in vivo studies.  Alternatively, empirical dose-response model have been derived by 
correlating DVH’ summary metrics such as D95 in external beam therapy, D90 in 
brachytherapy, and recently D70 in 90Y-microsphere studies (22, 23, 80–82).  Even though 
PET/CT images have been increasingly used for volumetric dosimetry calculation, the impact 
of signal starvation on the errors, both systematic and random, in the resulting DVH’ and it 
summary metric (e.g., Dmean and D70) is poorly understood. 
There has not been any standardization of 90Y PET image acquisition and 
reconstruction.  Recent studies on OSEM reconstruction-parameters optimization for 
quantitative 90Y PET imaging (24, 36–39) still used mean-activity-concentration recovery 
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coefficient as the objective function, which is more relevant to diagnostic dosimetry and 
detection tasks.   
In this work, we aimed to optimize 90Y-PET image-reconstruction protocol for 
volumetric 90Y dosimetry—calculated as DVH’.  We optimized the image-reconstruction 
protocol in a phantom studying using a modified NEMA IEC phantom study under a wide 
range of clinically relevant imaging condition: sphere sizes, activity concentrations, sphere-
to-background ratios, and acquisition durations.  While increase in equivalent number of 
iterations improves image resolution and quantification of mean activity concentration, it also 
increases the image noise.  After convergence is achieved, increase in equivalent number of 
iterations only results in higher image noise.  Application of Gaussian post-reconstruction 
filtration introduces image blurring and it can be used to reduce image noise; although it 
results in underestimation of the mean activity concentration with severity degree depending 
on the filter full width half maximum.   Image noise and partial volume effect are major 
degrading factors that limit  voxel-based dosimetry (40); hence, optimization of 
reconstruction parameters (equivalent number of iterations and post-reconstruction filtration 
FWHM) is imperative to improves the accuracy of DVH estimates calculated from noisy 90Y 
PET images (DVH’). 
3.2.  Methods 
We used a modified NEMA IEC phantom (Biodex, Shirley ,NY) to emulate 
clinically relevant 90Y PET imaging conditions thru various combinations of acquisition 
durations, sphere activity concentrations, sphere-to-background ratios (SBR), and sphere 
sizes. The modified IEC phantom contains 2 sphere sets of diameters 37, 17, 13 mm each.  
These sphere were filled with 90Y activity concentrations (AC) of 4.8 MBq/cc (130 uCi/mL) 
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and 1.6 MBq/mL (43 uCi/mL); the background chamber was filled with 0.4 MBq/mL 
(10 uCi/mL) to give SBR of 13 and 4. 
PET data of the IEC phantom were acquired in list-mode using GE D690 PET/CT 
scanner for 300 min in 1-bed position.  To optimize the quantitative image reconstruction, 
PET images were reconstructed using various parameter sets.  All PET images (AC map in 
Bq/mL) were multiplied by a scaling factor of  4.78×10-5 Gy.mL/Bq to convert the PET 
images to 90Y dose map (Gy) via local deposition method (35). 
To evaluate the variation of optimum reconstruction parameters under a range of 
image noise, we replayed the list-mode PET data to 60, 45, 30, 15, and 5 min with 10 
different realizations each.  We also acquired the PET list-mode data on day 0 (sphere ACs 
of 4.8 and 1.6 MBq/mL) and on day 3 (sphere ACs of 2.3 and 0.8 MBq/mL) to assess 
variation in reconstruction due to dose rate during acquisition. 
The PET/CT images were reconstructed using 3D-OSEM with PSF+TOF 
modelling (VPFXS).  The voxel size was 2.6 × 2.6 × 3.3 mm3.  Assuming local energy 
deposition, the corresponding known doses of the sphere sets were 230 and 77 Gy on day 0 
and 110 and 37 Gy on day-3 acquisition.  We optimized the image reconstruction parameter 
using both recovery coefficient (RC) of mean dose (section B.1.1) and minimum errors in 
volumetric 90Y dose quantification (section B.1.2) as the objective functions. 
 
3.2.1.  Reconstruction optimization based on recovery-coefficient convergence 
The reconstruction parameter optimized in this sub section was the number of 
equivalent iterations (subsets × iterations); where the objective function of the optimization 
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was recovery coefficient (RC) of mean sphere dose.  PET images were reconstructed using 
fixed subset of 12 and varying iterations of 1–12. 
The sphere RCs were calculated as RC = Dmean/Dtrue; where Dmean is the mean dose 
in the sphere computed from CT-contoured VOI, and Dtrue is the known absorbed dose in the 
sphere calculated based on the injected 90Y activity. 
The convergence properties of sphere RC were evaluated under aforementioned 
various imaging conditions: acquisition durations (300–5 min), sphere dose (230–37 Gy), 
SBR (13 and 4), and sphere sizes (37, 17, and 13 mm).  RC convergence was determined by 
calculating sphere RC as a function of number of equivalent iterations for images with no 
post-reconstruction filtration.   
 
3.2.2.  Reconstruction optimization based on errors in dose volume histogram 
estimates 
Here, the reconstruction parameters optimized were both the number of equivalent 
iterations and the full width at half maximum (FWHM) of the post-reconstruction Gaussian 
filters.  PET images were reconstructed using fixed subset of 12 and varying iterations of 1–
12.  The post-reconstruction Gaussian filters in the transaxial plane were varied from 0, 2.6, 
5.2, 7.8, and 10.4 mm.  The PET images (Bq/mL) were converted to dose map (Gy) and were 
corrected for dose-dependent systematic error in volumetric 90Y dose (Chapter 4). 
We optimized the image-reconstruction parameters for sphere (tumor) dose 
quantification; therefore the volumetric dose distribution in the all sphere sets (13, 17, and 
37-mm spheres with SBR of 13 and 4) were quantified using dose volume histogram estimate 
(DVH’).  The optimization objective function was minimum errors in the sphere DVH’.  
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Sphere DVH’ were derived from matching-sized volumes of interest (VOI) that were 
contoured from CT sphere images, e.g., DVH’ in the 17-mm sphere was derived from 17-mm 
spherical VOI.  Errors in the DVH’ were calculated as root mean square errors (RMSE) of 
the differences in the image-based sphere DVH’ and the true DVH, i.e., 𝑅𝑀𝑆𝐸 =
�∑ (𝐷𝑥−𝐷𝑡𝑟𝑢𝑒)28020
60
; where Dx is the minimum dose that covers x% of the VOI, and Dtrue is the 
known dose based on injected 90Y activity.  The true DVH was calculated for uniform sphere 
dose distribution as such that Dx for all volume coverage, x, equal to Dtrue.  RMSEs were 
calculated from D80 to D20 to avoid high errors near the maximum (D0) and minimum (D100) 
doses due to both systematic and random errors (section C.3.).  RMSE for each sphere DVH’ 
was calculated as an average of 10 different image noise realizations; the standard errors 
were also reported.  RMSE was calculated for all image-reconstruction-parameter 
combinations (equivalent iterations and filtration FWHM) under the same variation of 
imaging condition in section 3.2.1. 
 
3.3.  Results 
3.3.1. Reconstruction optimization based on recovery-coefficient convergence 
The convergence rates of VPFXS algorithm were found to be insensitive to various 
imaging conditions tested: sphere sizes, SBR, sphere dose (activity concentration), and 
acquisition duration.  Fig 12 demonstrated this convergence rate invariance for sphere with 
SBR of 13, sphere diameters of 37, 17, and 13 mm, and sphere dose of 230 and 77 Gy.  
Spheres with various imaging condition achieved RC convergence after 36 equivalent 
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iterations.   The systematic and random errors in converged RC were characterized in 
Chapter 4. 
 
Fig 12.  Mean dose recovery coefficient (RC) plotted as a function number of equivalent 
iterations (subset × iterations) for sphere with sphere-to-background ratio of 13, sphere sizes 
of 37, 17, and 13 mm, and dose levels of 230 and 77 Gy. 
 
 
3.3.2. Reconstruction optimization based on errors in DVH’ 
We found that images reconstructed using equivalent iterations of 24–48 and 
filtration FWHM of 5.2–7.8 mm, RMSE of sphere DVH’ were consistently among the lowest 
in various tested imaging conditions. 
  Fig 13 shows the DVH’ for 17-mm sphere images (SBR of 13, dose of 230 Gy, 
duration of 30 min) reconstructed using various equivalent iterations (Fig 13A) and various 
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filtration FWHM (Fig 13B).  Their RMSE of DVH’ are shown in Fig 13C as a function of 
equivalent iterations and filtration FWHM.  The standard errors of selected DVH’ RMSE are 
also shown as the error bars.   RMSEs of DVH’ were among the lowest at 36 equivalent 
iterations; further increase in the number of equivalent iterations beyond 36 resulted in higher 
noise, as evident in the increase spread of DVH’ (longer tails on both ends).  Similarly, the 
RMSE of DVH’ was the lowest with filtration FWHM of 5.2 mm.  Heavier filtration shifted 
the DVH’ toward lower dose and resulted in higher underestimation of DVH’. 
The DVH’ RMSE in a larger sphere image (37 mm in diameter) was the lowest at 
equivalent iteration of 24, while the RMSE in a smaller sphere image (13 mm in diameter) 
was the lowest at 48 equivalent iterations.  However image reconstruction of all spheres 
(diameter of 37–13 mm) using 36 equivalent iterations resulted in change of absolute errors 
in DVH’ of < 1% at all volume coverage (Fig 13A and Fig 13C). 
As the sphere image noise/non-uniformity increases due to lower dose or shorter 
duration, 7.8-mm filtration resulted in lower RMSE of DVH’ than did images with 5.2-mm 
filtration.  Changes in 17-mm sphere (77 Gy) DVH’ calculated from sphere images (15-min 
duration) with 5.2 and 7.8-mm filtration were < 3% at volume coverage between 20–80%, on 
average. 
While application of image filtration suppresses image noise and hence reduces 
noise-dependent errors in DVH, it also increases the errors in DVH due to increased partial 
volume effect.  Heavier filtration with FWHM of 7.8 and 10.4 can be used on larger sphere 
(37-mm sphere), where partial volume effect is less severe, to further reduce the RMSE of 
DVH estimate; heavier filtration beyond 7.8-mm FWHM, however, did not significantly 
improve the DVH’ (< 2% absolute change at all volume coverage).   In contrast, application 
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of filtration with FHWM wider than 5.2 mm increased the RMSE of DVH’ in smaller 
spheres, e.g. in 17-mm sphere (Fig 13B and Fig 13C). 
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Fig 13.  Dose volume histogram estimates (DVH’) of 17-mm sphere (230 Gy) calculated 
from 15-min sphere images reconstructed with (A) equivalent iterations of 12–48 (filtration 
full width at half maximum [FWHM] of 5.2 mm) and (B) from images reconstructed with 
FWHM of 2.6–10.4 mm (equivalent  iteration of 36).  The black curve indicates the adjusted 
reference DVH.  (C) The root mean square error (RMSE) of DVH’ as a function of 
equivalent iterations and filtration FWHM for 17-mm sphere image (230 Gy, 15 min). 
3.4.  Discussion 
3.4.1. RMSE dependence on dose threshold selection 
To determine the sensitivity of RMSEs to selection of dose threshold ranges, we 
also investigated the random error in RMSE trends as a function of dose threshold ranges: D0 
– D100, D10 – D90, D20 – D80, D30 – D70, D50 – D80, D60 – D90.  As expected, using the entire 
dose threshold range from D0-D100, the RMSE was the lowest when using lower number of 
equivalent iterations to avoid high errors due to noise near the extreme doses.  The resulting 
DVH, however, yields higher errors in more useful dose metrics, e.g. D20-D80, as shown in 
Fig 13 and Fig 14.  RMSE calculation using other dose threshold ranges between D10-D90 
results in similar RMSE trend as a function of equivalent iterations, i.e., RMSE was the 
lowest at 36 equivalent iterations with 7.8-mm filtration (Fig 14).  We chose dose threshold 
range of D20-D80 as a conservative approach to avoid noise-related errors near the extremes, 
which cause both high errors (Fig 13) and high random error (Fig 21A). 
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 Fig 14. Root mean square errors (RMSE) of 17-mm sphere (110 Gy) dose volume histogram 
(DVH) estimate for various dose threshold ranges.  Using the entire range D0–D100 results in 
an optimization systematic error where low number of equivalent iterations is preferred to 
avoid high errors due image. 
3.4.2.  Comparison of optimization objective functions: traditional mean dose RC 
versus DVH’ RMSE. 
As the numbers of equivalent iterations increases, the sphere images begin to 
converge, but the image noise increases as well.  Transaxial filtration can be used to reduce 
the image noise, but it blurs the image, which results in changes in dose distribution 
(smeared) with degree of severity depending on the FWHM of the filtration and the sphere 
sizes.   
Optimization using mean dose RC does not take into account the alteration in dose 
distribution due to changes in image noise: increase noise from higher number of equivalent 
iteration and reduced noise from higher filtration FWHM.  Since spatial filtration reduces the 
mean dose RC, reconstruction-parameter optimization using mean dose RC as the objective 
function would suggest minimum filtration.  As shown in Fig 13, sphere images with no/low 
filtration resulted in higher errors in DVH. 
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While the standard deviation of the mean dose RC can be used to minimize the 
increase noise from higher number equivalent iteration, it cannot be used to optimize the 
FWHM of the filtration.  Wider FWHM filtration will monotonically result in lower standard 
deviation. 
Although in clinical practice, post-reconstruction filtration is usually applied to 90Y 
PET images, the FWHM of the filtration is not being optimized for volumetric quantification 
task.  Post reconstruction filtration is normally considered to improve detection only.  In this 
work, we showed that filtration can be used to improve volumetric quantification; therefore 
for volumetric quantification task, the FWHM of the filtration applied to the 90Y PET 
images need to be optimized (or verified) based on minimum errors in the DVH. 
 
3.4.3.  Study limitation  
This study was limited to phantom studies using a modified NEMA IEC phantom.  
Spheres with uniform dose were not true representations of heterogeneous 90Y-microsphere 
distribution in the tumor.  Future studies using a physical phantom (83) with inhomogeneous 
90Y distribution are needed to further evaluate the errors in volumetric 90Y dosimetry 
calculated from 90Y PET images. 
3.5.  Conclusion 
Using DVH’ as an objection function allows optimization of both number of 
equivalent iterations and FWHM of the post-reconstruction filtration.  We recommend using 
36 equivalent iterations with 5.2-mm filtration for 90Y-PET image reconstructed using 
VPFXS (GE OSEM with TOF and PSF). 
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Chapter 4: Quantitative 90Y-PET image reconstruction: systematic (bias) and random 
(variability) errors. 
4.1.  Introduction 
This chapter is a continuation from Chapter 3, where we used the optimized image-
reconstruction protocol discussed in Chapter 3 to generate 90Y dose map of the modified IEC 
phantom.  In this chapter, we characterized the systematic and random errors in the resulting 
sphere DVHs’.   We evaluated the dose-dependent systematic error in quantitative 90Y PET 
images (in GE D690/D710) that have been reported by several groups on different PET 
scanner makes and models (37, 39, 66, 84).  Then we assessed the unique challenge in 90Y 
PET, i.e., very low signal acquired.  Low signal introduces increased non-homogeneity 
(image noise) in dose distribution, resulting in systematic error in DVH’.  In addition, low 
signal also increases the random errors in DVH’ measurement, both of which contribute to 
total error in DVH’, consequently reducing the predictive value of dose-response model. 
In clinical practice, the dose metrics are calculated from a single measurement (e.g. 
PET image set).  Dose metrics used to predict tumor response ideally should have very high 
correlation to response metric and have low errors (systematic and random) so as to maintain 
clinically acceptable predication intervals.  These PET based metric with high errors will, 
despite their high correlation, will have large prediction intervals; hence we need to trade-off 
the degree of correlation and the errors in the dose metric used. 
Mean tumor dose (Dmean) has been shown to have correlation with tumor response 
(73, 85).  However, in tumor with heterogeneous dose distribution, the correlation between 
mean dose and response will be weaker.   Minimum dose (D100) to tumor, in principle, would 
have the highest correlation with tumor response.  Minimum dose, however, is prone to 
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errors (contouring uncertainty, noise in image-based dosimetry, etc).  Due to this uncertainty 
in minimum dose, dose metrics will less errors (despite lower correlation, theoretically) are 
being used in radiation oncology (for example, D95 in external beam therapy, D90 in 
brachytherapy). Therefore, accurate measurement of DVH for 90Y therapies are needed and 
then those metric need to be correlated with response to establish the appropriate dose metric 
for SIRT; there are some suggestions that D70 is of clinical relevance in 90Y SIRT. 
The correlation between dose and response metrics require clinical data, which we 
currently do not have.  Errors in the dose metrics, however, can be studied in phantom study 
acquired under clinically relevant imaging condition.  In our study, we characterized the 
errors of dose volume histogram (DVH) metrics at volume coverage of 20–80% and Dmean, 
depending on the noise level, is at D20–D50%.  The findings in our study will help future 
study by providing some reference 1) in calculation of sample size needed to determine 
statistically meaningful dose-response model, and 2)  in the confidence interval of dose 
metrics calculated from a single measurement (from patient images/dose map).  Information 
about the overall errors of the dose metrics can be used as a reference to compare the 
predictive power of different dose-response models (e.g., Dmean -response vs D80-
response). 
4.2.  Methods 
We used a modified NEMA IEC phantom (Biodex, Shirley ,NY) to emulate 
clinically relevant 90Y PET imaging conditions thru various combinations of acquisition 
durations, sphere activity concentrations, sphere-to-background ratios (SBR), and sphere 
sizes. The modified IEC phantom contains 2 sphere sets of diameters 37, 17, 13 mm each.  
These sphere were filled with 90Y activity concentrations (AC) of 4.8 MBq/cc (130 uCi/mL) 
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and 1.6 MBq/mL (43 uCi/mL); the background chamber was filled with 0.4 MBq/mL 
(10 uCi/mL) to give SBR of 13 and 4. 
PET data of the IEC phantom were acquired in list-mode using GE D690 PET/CT 
scanner for 300 min in 1-bed position.  To optimize the quantitative image reconstruction, 
PET images were reconstructed using various parameter sets in section B.1.  For the rest of 
the study (section B.2.—B.3.), all PET images were reconstructed using the optimal 
parameter set derived in section B.1. 
All PET images (AC map in Bq/mL) were multiplied by a scaling factor of  
4.78×10-5 Gy.mL/Bq to convert the PET images to 90Y dose map (Gy) via local deposition 
method (35). 
 
4.2.1.   Dose-dependent systematic error in volumetric 90Y-dose quantification 
To separate the errors due to prompt rate and prompt count, we compared the errors 
in mean dose as the 90Y activity decayed (rate and count effect) to the errors as the 
acquisition duration decreased (count effect only).  We acquired 300-min list-mode PET data 
of the modified 90Y IEC phantom for 11 consecutive days.  As the 90Y activity decayed, both 
the total prompt rate and the total prompt counts decreased.  We also down-sampled the 300-
min list-mode data to shorter duration: 120, 60, 20, 10, 5 min.  For images with 60–5min 
duration, we down-sampled them at 10 different noise realizations.   
For all images, the mean dose (with no partial volume effect [PVE]), Dmean, no PVE, 
was computed as the mean dose in 37-mm sphere images calculated using a 17-mm VOI to 
minimize PVE and random error due to VOI placement.  We also computed the mean dose in 
the background region as an average of Dmean, background from 5 17-mm VOIs scattered in the 
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background region.  The errors in Dmean, no PVE and Dmean, background were calculated with respect 
to Dtrue, i.e., 1 − Dmean,no PVE/Dtrue.  For the 300-min images at different dose level 
(different days), we used polynomial data fitting to model the errors as a function of Dtrue for 
mean dose in both 37-mm spheres (SBR of 13 and 4) and the background.  This empirical 
model was used to correct for the dose-dependent systematic error in Dmean, no PVE .  We 
quantified the errors in DVH’ calculated from sphere dose distribution with and without the 
empirical dose-dependent systematic error correction.  
For the images with reduced durations, we only characterize the errors as a function 
of Dtrue for mean dose in 37-mm spheres with SBR of 13.  The errors were calculated as an 
average of errors in 10 noise realizations, and their standard errors were also calculated.  The 
relationships between the errors in Dmean, no PVE and the known dose were compared in both 
activity decay and acquisition duration reduction using linear regression method. 
The volumetric dose distributions of spheres with different activity (dose) level but 
comparable number of true prompt event were compared to assess if there were alteration in 
the dose distribution beyond the systematic error in Dmean, no pve.  We selected several 37-mm 
sphere images at different dose levels (e.g., 230, 100, 11 Gy) and we matched the number of 
true prompt event level by varying the acquisition duration (e.g., 15, 30, 300 min, 
respectively) such that the product dose and acquisition duration were comparable.  The 
DVH’ of these 37-mm sphere images were calculated from 17-mm VOI and normalized such 
that the area under the curve equaled to unity.  Agreement of the normalized DVH was 
measured as the (max-min)/average at all volume coverage, i.e., D0 to D100. 
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4.2.2.  Comparison between 90Y and equivalent 18F studies 
A total of 111 kBq (3 µCi) of 18F was injected into the modified IEC phantom (SBR 
of 11 and 3) to simulate the inherent low count and high random fraction (random event/total 
prompt) typical of 90Y studies.  18F activity of 3 µCi resulted in positron emission rate of 
108 kcps, which was equal to the positron rate from 3.37 GBq (91 mCi) of 90Y activity.  PET 
list-mode data of this 18F phantom were acquired for 12 hours and were down-sampled to 12 
× 30-min separated by 1 hour each.  The 300-min PET-list mode data (day 1 to day 11) for 
similar 90Y phantom study were down-sampled to 10 contiguous 30-min scans to match the 
scan duration for 18F. 
All 18F PET images were reconstructed using the same optimized parameters used 
to reconstruct 90Y PET images (section B.1.).  At each time point, we calculated the mean 
absorbed dose, Dmean, no pve, in 37-mm sphere (SBR 11) from 17-mm VOI and we also 
calculated their errors with respect to the known dose from assay.  Errors in Dmean, no pve were 
characterized as a function of known positron emission rate and compared to the errors in 
Dmean, no pve from 90Y study using linear regression analysis to determine the correlation 
between the errors and the positron emission rate (activity).  In addition, we also compared 
the total prompt and number of random events (retrieved from the DICOM tags) in both 18F 
and 90Y studies as a function of positron emission rate. 
To measure the contribution of internal background radiation from lutetium-176 
yttrium orthosilicate (LYSO) crystal, we acquired an 8-hour blank scan of the background 
radiation with just air in the FOV.  The number of random events in 30-min acquisition was 
calculated to match the acquisition duration of 18F and 90Y studies. 
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4.2.3.  Impact of low signal on volumetric 90Y dose quantification  
To investigate the impact of low signal acquired on accuracy and random error of 
the sphere DVH’, we varied the number of true event acquired by reducing the acquisition 
duration.  The 300-min list-mode PET data were down-sampled with multiple noise 
realizations to 5 × 60 min, 6 × 45 min, 10 × 30 min, 10 × 25 min, 10 × 20 min, 10 × 15 min, 
10 × 10 min, 10 × 5 min.  PET images were reconstructed using optimized reconstruction 
parameters for post-therapy quantitative 90Y PET imaging (Chapter 3).  The PET images 
were converted to dose map and were corrected for dose-dependent systematic error (Chapter 
4.2.1) 
4.2.3.1.  Impact of image noise on volumetric 90Y dose quantification accuracy 
The impact of noise in accuracy of both differential (more intuitive approach) and 
cumulative dose histogram estimates (DVH’) were evaluated in sphere images with minimal 
PVE.  VOI with 17-mm diameter was used to calculate DVHs’ in the 37-mm sphere (SBR 
13, 230 Gy) images with various durations.  At each duration, the DVH’ were calculated as 
averages of multiple noise realizations.  The magnitude of errors in DVH’ due to noise 
(minimal PVE) were compared to the errors from PVE (low noise).  DVHs’ were calculated 
from the 300-min sphere images (low noise) for both 37- and 17-mm using VOI with 
matching sizes to appreciate the PVE. 
DVH’ accuracy in clinically relevant imaging condition was evaluated in the 
presence of both PVE and image noise.  The 300-min list-mode PET data (11-consecutive 
day acquisition) were down-sampled to 10 × 30 and 10 × 10 min for each day, spanning 
known sphere dose of 11–230 Gy.  The tumors were emulated using the 37- and 17-mm 
spheres.  Sphere DVH’ were calculated as an average of 10 noise realizations and were 
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calculated using matching-size VOI.  DVH’ accuracy were characterized as a function of 
known dose at Dmean, D80, and D20 for both sphere sizes and acquisition durations. 
 
4.2.3.2.  Impact of low signal on volumetric 90Y dose quantification random error 
We evaluated the data from Chapter 4.2.3.1.  The random error of the DVH’ was 
calculated as the coefficient of variance (COV = standard deviation/average) of Dx for all 
volume coverage, x, in10 noise realizations.  We calculated the COV of Dx in 37- and 17-mm 
sphere images acquired for 30 and 10 min.  The maximum COV of Dx (for 20 ≤ x ≤ 80) was 
characterized as a function of known dose. 
 
4.3.  Results 
4.3.1.   Dose-dependent systematic error in volumetric 90Y-dose quantification 
We observed a non-linear relationship between known dose and measured 
volumetric dose quantification in both spheres and background VOI.  Fig 15A shows 
measured Dmean,no pve in 37-mm spheres and background region as a function of known Dtrue.   
Dmean, no pve in both spheres and background VOI showed quadratic relationship (0.0005x2 +0.72x − 1.42) with the Dtrue; where x is decay corrected Dtrue.  Consequently, the errors in 
measured Dmean, no pve, calculated as Dmean, no pve/Dref  -1, showed dose-dependent systematic 
error that was consistent with quadratic relationship, i.e., (0.0005x + 0.72 − 1.42/x), shown 
in Fig 15B.  In contrast, the errors in Dmean, no pve calculated from sphere images with reduced 
duration did not exhibit noise-dependent errors (Fig 15C).  The standard errors of the errors 
in Dmean, no pve  for 60 to 5-min images were < 0.5%, shown but not visible in Fig 15C.  The 
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slope of the errors vs. fractional count (duration) was consistent with zero with p value >> 
0.05, while the slope of the errors vs. fractional count (activity) was clinically significant 
with p value << 0.05. 
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Fig 15(A) Measured mean absorbed dose Dmean, no pve (with minimal partial volume effect) in 
sphere and background regions as a function of known dose (from assay) showing a 
quadratic relationship. (B) The errors in Dmean, no pve as a function of known dose showing an 
dose-dependent errors in Dmean, no pve.  (C) Comparison of error trends in Dmean, no pve of 37-mm 
sphere (SBR 13) vs. fractional count.  The fractional count is varied by reducing the 
acquisition duration (orange line) and by letting the activity decay (red line). 
 
The alteration in volumetric 90Y-dose quantification due to this dose-dependent 
systematic error was found to be scalar, i.e., the relative dose distribution was not varied by 
this dose-dependent systematic error, as evident in the agreement in normalized DVH’ of 
sphere images at different dose level (different errors) with equivalent noise.  Fig 16A shows 
that the normalized DVH of 37-mm sphere with dose of 230, 100, and 11 Gy agree within 
4%, which was consistent with their measurement random error (Chapter 4.3.3.2.).  The 
dose-dependent errors in Dmean, no pve were -20%, -24%, and -34% for sphere dose of 230, 100, 
and 11 Gy, respectively. 
Fig 16B shows the DVH’ (minimum partial volume) of 37-mm sphere (known dose 
of 110 Gy) for acquisition duration of 30 min with and without correction for dose-dependent 
systematic error.  After the correction for the dose-dependent systematic error, the error in 
Dmean, no pve was reduced from -22% to +2%; while the error in D80 was reduced from -36% to 
-15%.  The overestimation in Dx for volume coverage x >50% was consistent with the 
systematic error introduced by the image noise (Chapter 4.3.3.1). 
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 Fig 16.  (A) Agreement between normalized dose volume histograms estimate (DVH’) 
calculated from 37-mm spheres images (17-mm volume of interest) with comparable image 
noise, i.e., equivalent number of true coincidence (dose rate × acquisition duration).  (B) 
DVH’ before and after correction for dose-dependent systematic error. 
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4.3.2.  Comparison between 90Y and equivalent 18F studies 
Dose-dependent, which were seen in 90Y study, were not observed in 18F study with 
equivalent positron emission rates.  Fig 17A shows errors in Dmean, no pve as a function of 
positron emission rate (or equivalent 90Y activity) for both 18F and 90Y studies.  The errors in 
18F had higher uncertainty due to their single 30-min acquisition duration compared to 10 
repeat scans of 30-min acquisition for each 90Y data point.  The correlation of the errors and 
positron emission rate in 18F study was not clinically and statistically significant with slope of 
0.0006 and p-value of 0.5.  In contrast the errors in Dmean, no pve and positron emission rate had 
strong correlation with slope of 0.07 and p-value of 0.007. 
At clinical 90Y equivalent positron emission rate, the random fraction (random 
events/total prompt) in both 90Y and 18F data were very high.  Fig 17B shows that the random 
events dominated the total prompts in both 90Y and 18F studies.  The number of random 
events in 90Y data, however, was higher than it was in 18F data with equivalent number of 
true coincidence. 
Because of the very low PET signal (low positron emission rate), the random events 
associated annihilation photons are low as well.  Fig 17B shows that the number of random 
events in 18F data was dominated by LYSO background; as the positron emission rate 
(activity) increased from 2 to 75 kcps, the number of random events only increased from 1.50 
to 1.53 Mcount.  On the other hand, the major contributors to the number of random events in 
90Y data were LYSO background and bremsstrahlung photons.  The number of random 
events increased from 2.34 to 4.95 Mcounts as the positron emission rate increased from 4 to 
75 kcps (0.13 to 2.36 GBq 90Y).  The number of random events due to LYSO background 
was calculated to be 1.55 Mcount in 30-min blank scan, which was consistent with zero 
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extrapolation from random events in 18F study.  In contrast, there seemed to be an 
overestimation in the LYSO background contribution in 90Y data; zero extrapolation from 
random events in 90Y was 2.13 Mcount. 
 
 
 
Fig 17 (A) Errors in mean dose of 37-mm sphere image (calculated using 17-mm volume of 
interest) as a function of positron emission rate (or equivalent 90Y activity) for both 18F and 
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90Y in similar phantom studies. (B) Number of coincidence events in the scanner FOV as a 
function of positron emission rate from 18F and 90Y phantom studies in (A).  Note: P: total 
prompt, R: random coincidence, T+S: true + scatter coincidence 
4.3.3.  Impact of low signal on volumetric 90Y dose quantification  
4.3.3.1.  Impact of image noise on volumetric 90Y dose quantification accuracy 
We observed that the low count acquired in PET data increased the non-uniformity 
(image noise) in the dose distribution.  Due to the non-negativity constraint of the voxel 
values in the image-reconstruction algorithm, the observed dose distribution was positively 
skewed, i.e. the dose distribution had a long tail toward high dose while the mass of the 
distribution was concentrated on the lower dose, as shown by the differential dose histogram 
in Fig 18A for 37-mm sphere (minimal PVE, reference dose of 60 Gy) under multiple 
acquisition durations.  The degree of skewness, calculated as Pearsons’ 2nd skewness 
coefficient, increased as the image noise increased (with shorter acquisition duration and/or 
lower dose).  The Dmedian had increased negative deviation from Dmean as the acquisition 
duration was reduced, Fig 18B.  Image noise introduced errors in the sphere DVH estimate as 
shown in Fig 18B for 37-mm sphere with known dose of 230 Gy.  Away from the average 
dose (Dmean) the DVH metrics (Dx) toward the minimum dose (D100) were underestimated 
and toward the maximum dose (D0), Dx were overestimated. 
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Fig 18.  (A) Images of modified IEC phantom acquired for 300, 20, and 5 min.  The sphere 
doses are 230 and 77 Gy with SBR of 13 and 4, respectively.  (B) Differential and (C) 
cumulative volume histogram in 37-mm sphere image acquired for multiple acquisition 
duration.  The histograms were calculated using 17-mm volume of interest to minimize 
partial volume effect. 
Fig 19 shows the DVH’ of the 17-mm sphere with PVE, and DVH’ of the 37-mm 
sphere with and without PVE.  The sphere dose was 230 Gy and the images were acquired 
for 300 min (solid lines) and 10 min (dash lines).  With minimal PVE, the magntidue of 
errors in D80 increased from -3.4% to -22.7% when the acquisition duration was reduced 
from 300 to 10 min.  The errors in Dmean, no PVE were relatively insensitive to noise, the errors 
increased from -0.2% to -2.5% as the duration was reduced. 
PVE caused underestimation in DVH’ at all volume coverage (Fig 19).  The errors 
in Dx were higher toward minimum dose, i.e., when the volume coverage (x) was high.  The 
errors in 37-mm sphere DVH’ calculated from 300-min sphere images were -29.7%, -12.5% 
at D80, and Dmean, respectively; whereas the errors in 17-mm sphere (300 min) DVH’ were --
55.4%, -32.4% at D80, and Dmean, respectively.    The confounding errors from image noise 
were minimal in the DVHs calculated from 300-min images: < 5% between D5 and D95, and 
< 10% outside D5–D95.  In the presence of PVE, the additional errors due to acquisition 
reduction from 300 to 10 min were ~10% and <5% for both 37- and 17-mm sphere.  These 
additional errors were slightly lower (1%–2%) in 17-mm sphere, which suffered more PVE, 
than they were in 37-mm sphere DVH.   
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 Fig 19. Dose volume histogram (DVH) of spheres with 3 degrees of partial volume effect 
(minimum, 17- and 37-mm sphere) and 2 acquisition durations (300 and 10 min).   
 
Fig 20 shows the errors in 17-mm sphere DVH’ (D20, Dmean, and D80) as a function 
of known sphere dose for both 30-min (solid lines) and 10-min (dash lines) acquisition 
duration.  For acquisition duration of 30 and 10 min, the errors in DVH estimates (D20—D80) 
between known dose of 60—240 Gy were not sensitive (< 10% change) to changes in dose.  
At known sphere dose of < 60 Gy, the magnitude of errors started to increase. 
The average errors in DVH’ for 17-mm sphere with known dose of 60—240 Gy 
were  -8%, -33%, and -57% at D20, Dmean, and D80, respectively, for 30-min scan; while, the 
errors in DVH’ calculated from 37-mm sphere images (30-min scan) were +12%,  -10%, and 
-34%, respectively.  At shorter acquisition duration of 10 min, the additional errors in the 
DVH estimates for 17-mm sphere images were -10% and -1% at D80 and D20, respectively.  
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For DVH estimates of 37-mm sphere images, the additional errors were +5% and +11% at 
D80 and D20, respectively. 
 
 
Fig 20. Errors in D80, D20, and Dmean as a function of known dose for 17-mm sphere.  The 
solid and dash lines indicate errors in 30- and 10-min acquisition, respectively.  
 
4.3.3.2.  Impact of low count on volumetric 90Y dose quantification random error 
The COV of DVH estimates was lower in 37-mm sphere and 30-min duration.  Fig 
21A shows COV of DVH estimates as function of volume coverage for sphere sizes of 37- 
(solid lines) and 17-mm (dash-dot lines) spheres, and acquisition duration of 30 and 10 min.  
We found that the COV was the highest around the minimum dose (D80 to D100) followed by 
the maximum dose (D0 to D20); whereas between D20 to D80 the COV was the lowest and 
stable (< 10% change). 
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In clinically relevant tumor dose of 60—230 Gy, the COV (between D20 to D80) of 
37-mm sphere DVH estimates was < 5% and < 10% for acquisition duration of 30 and 
10 min.  For 17-mm sphere DVH estimates, the COV (between D20 to D80) was < 15% for 
acquisition duration of 30 min.  DVH estimates of the 17-mm sphere that were calculated 
from 10-min sphere images suffered from higher random error.  At a known sphere dose of 
110 Gy, the COV (between D20 to D80) of DVH estimates was already 20%.  Fig 21B shows 
the maximum COV (between D20 to D80) as a function of known dose. 
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 Fig 21. (A) Coefficient of variation (COV) in 37- and 17-mm sphere DVH estimates (with 
known dose of 230 Gy) calculated from 30- and 10-min images with 10 noise realizations. 
(B) Maximum COV (between D20 and D80) in 37- and 17-mm sphere DVH estimates as a 
function of known dose.  Note: the solid and dash-dot lines represent 37- and 17-mm spheres, 
respectively. 
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4.4.  Discussion 
4.4.1.  Dose-dependent errors in volumetric 90Y dose quantification 
We characterized the errors in Dmean, no pve as a function of known dose and 
compared them to the errors in Dmean, no pve as a function of duration (Section C.2.1).  The 
correlation between errors in Dmean, no pve and acquisition duration (fractional count) was 
found to be practically (< 1% change in errors going from 300- to 5-min duration) and 
statistically (p value of the slope >> 0.05) insignificant; hence suggesting that the errors trend 
observed from images with decayed dose level was related to the dose (activity) only and not 
related to image noise. 
True, scatter, and random contribute to the total prompt acquired.  Among these 
components, random is the only quadratic component.  In this work, the random correction 
was done using estimation from singles, i.e., R ≅ S1S2ΔT, where R is the random rate, S1 and 
S2 are the single rates, and ΔT is the timing resolution.  The quadratic relationship (Fig 15A 
and Fig 15B) between measured Dmean, no pve suggests that the random was not properly 
corrected which resulted in an dose-dependent errors in Dmean,no pve.  This hypothesis is also 
supported by comparison with 18F study with comparable positron emission rate to 90Y.  In 
our 18F phantom study, when positron emission rate is < 20 kcps, the random fraction 
(random event/total prompt) is >90% (Fig 17B), which is comparable to the random fraction 
observed in clinical 90Y study.  However, even with similar random fraction, no dose-
dependent systematic errors were observed in 18F study.  Comparison to trace amount of 18F 
study suggests that the dose-dependent systematic errors observed in 90Y is caused 
predominantly by the imperfect correction of random events from bremsstrahlung photons—
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which is absent in 18F study—rather than from background radiation in the detector from 
LYSO crystal, as suggested by previous study (66). 
The overall errors in sphere DVH’ that we showed in section C.3.1. were corrected 
for the activity-dependent errors.  In clinical practice, it may not be possible to correct for 
these dose-dependent systematic errors (section C.2.1.) because of the confounding errors in 
measured mean dose.  Without correction for dose-dependent systematic error, the additional 
systematic error in volumetric dosimetry for tumor with average dose of 40–230 Gy is -20% 
to -30% (Fig 15B), whereas the systematic error in dose quantification in the normal tissue (< 
30 Gy) is ~5–10 Gy. 
 
4.4.2.  Systematic and random errors in quantitative 90Y -PET imaging in clinical 
practice 
The unique challenge in 90Y PET imaging is that it has a very low signal (32 ppm 
positron yield), which introduced systematic errors (Fig 18) and random error (Fig 21), both 
of which result in errors in DVH’ (Chapter 4.3.3).   Systematic errors in DVH’ due to 
increased image noise can be reduced by “minimizing” equivalent iteration and 
“maximizing” filtration FWHM (section C.1.2.).   Through image reconstruction 
optimization, the additional systematic error in DVH’ due to image noise can be kept < 10% 
(in addition to > 50% total systematic error) even at low tumor dose of 40 Gy and image 
acquisition duration of 10 min (Fig 19 and Fig 20). 
The random error in DVH’ measurement can only be reduced by increasing the 
signal acquired.  For a given PET imaging system, the only adjustable parameter is the 
acquisition duration (or table speed in continuous bed motion mode.  For GE D690/D710, at 
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acquisition duration of 30 min, the random error in measured DVH’ can be kept < 10% even 
in 17-mm sphere with low dose (40 Gy); while at acquisition duration of 10 min, the random 
error in DVH’ is > 20%.  Therefore, to keep the additional errors (systematic and random) in 
DVH’ < 20% for a typical tumor in hepatocellular carcinoma (HCC)—equivalent sphere 
diameter of > 17 mm and mean tumor dose > 60 Gy—ideally 90Y PET data need to be 
acquired for 30 min.  In clinical practice, the prescribed scan length for 90Y-microsphere liver 
scan is 2 bed positions for majority of the patients; hence scan duration needed would be 2 
× 30 min, which will likely be the maximum duration in clinical practice. 
At lower count study, e.g. shorter duration and/or lower activity concentration, 
the COV is higher toward minimum dose D100.  The COV differences of D20 and D80 of up to 
10% were observed.  For decent statistic (duration of 300 min, dose of 230 Gy), Dmean 
approximately equals to D50, however, Dmean is closer to D30 at low statistic (duration of 
10 min, dose of 230 Gy).  Consequently, the COV in Dmean at low statistic can be up to 10% 
lower than D80.  The errors in DVH also increase with increase in image noise, a 
manifestation of low count data.  The magnitudes of errors in DVH are the smallest at Dmean, 
whose location in the DVH varies between D20–D50 depending on the image noise, and the 
highest toward D0 and D100.  In addition, because of the magnitude of the errors in D80 are 
higher, the random errors are also higher. Therefore for summary metrics such as D80 or D70 
will have higher systematic errors and random errors than Dmean. 
Without activity-dependent correction, the measured Dmean in tumor (> 27 mL) PET 
images acquired (using GE TOF scanners (D690 and 710, without prompt gamma correction) 
will have errors of -20%, -25%, and -30% at measured mean dose of 200, 100, and 50 Gy.  
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For tumor with smaller size (e.g. 2.6 mL), the errors are about 10% higher due to partial 
volume effect.  The uncertainty is < 5% for tumor Dmean of dose > 50 Gy (both 30- and 10-
min durations). 
The underestimation in Dmean is increasing from -30% to -35% when Dmean 
decreases from 50 to 10 Gy (dose level relevant to normal tissue).  The uncertainty in 
Dmean of normal tissue is low (<5%) as well for both acquisition durations of 10 and 30 min 
because the volume of interest for normal tissue is usually large (>> 27 mL). 
Another consideration for determining the acquisition duration is whether or not to 
perform (gating-based) motion correction for liver, which is subject to breathing motion.  
With quiescent-period-gating method, the systematic errors in DVH’ in motion-degraded 
images can potentially be reduced to < 10% —which is consistent with our finding here 
where the additional systematic error in DVH’ due to reduced duration is <10%—at the 
expense of increase random error because the images were reconstructed using 33% of the 
total counts (effectively reducing the duration by 1/3).  
Caution needs to be exercised when comparing dose data from published reports.  
Major challenges in comparing dose (Gy) are dosimetry models (standard vs partition vs 
image based), input images (PET vs 90Y microsphere bremsstrahlung SPECT vs 99mTc-MAA 
SPECT).  In our study using GE TOF scanners, we learned that even with the same PET-
based dosimetry, the discrepancies in quantification of PET image from different scanner 
models (and image reconstruction) makes it difficult to make direct dose comparison.  The 
errors in Dmean that we reported in GE TOF scanners are different from the errors observed 
in Siemens or Philips scanners. 
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Going forward, dose reporting needs to include the estimated errors (both 
systematic and random) in order to be able to make “Gray” a meaningful unit again.  Unless 
these errors are reported, we cannot compare the dose value reported in other publications. 
The QUEST study by Willowson et al (66) characterized the average systematic 
errors in various make and model of PET scanners.  This study can be used to translate PET-
based dose value. 
 
4.4.3.  Partial volume effect  
Partial volume effect (PVE) blur the sphere images, as a result the image (activity 
concentration [Bq/mL] distribution) of a uniform sphere is not uniform with the measured 
activity concentration higher at the center than at the edge of the sphere image.  The PVE is 
more severe in sphere with smaller diameter.  Due to PVE, the sphere DVH deviates from the 
ideal rectangular DVH. 
Dose map of a sphere with uniform 90Y activity distribution is not uniform because 
the electrons deposit their energy as they stagger in the sphere with average range of 4 mm 
and max range of 11 mm.  The point at the center of the sphere will have highest dose 
because it receives the energy from all the high activity concentration distributed in the 
radius of 11 mm.  A point at the edge of the sphere will have lower dose because it receive 
energy partially from high activity distribution in the sphere and also from low activity 
distribution in the background.  As a result the dose map is a blurred version of the ideal 
uniform sphere image. 
Using local deposition method (LDM), the sphere PET image (Bq/cc) is 
proportional to the dose map (Gy), i.e., the relative distributions are the same.  Both sphere 
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PET images and sphere true dose map are a blurred version of the ideal uniform sphere 
image; hence the effect of image PVE on dose map calculated using LDM is reduced.  The 
errors of PET-based dose map (LDM) with respect to the true dose map will be higher if the 
PET resolution is much different to the FWHM of the dose-kernel, e.g. resolution in the order 
of centimeter or sub-millimeter. 
 
4.4.4.  Study limitation  
This study was limited to phantom studies using a modified NEMA IEC phantom.  
Spheres with uniform dose were not true representations of heterogeneous 90Y-microsphere 
distribution in the tumor.  Future studies using a physical phantom (83) with inhomogeneous 
90Y distribution are needed to further evaluate the errors in volumetric 90Y dosimetry 
calculated from 90Y PET images. 
PVE is the dominant source of systematic errors in DVH’ even in count-limited 90Y 
PET images (Chapter 4.3.3).  In this work, we did not perform partial volume correction 
beyond using PSF correction option in the image reconstruction.  Even though application of 
post-reconstruction filtration increases PVE, we have shown in section C.1.2 that application 
of moderate filtration (5.2-mm FWHM, in this case) results in less systematic errors in 
DVH’.  Voxel size and z-axis filtration were not evaluated in this work.  Both parameters can 
potentially be optimized to trade-off the systematic error and random error in DVH’. 
Partial volume effects are often compensated (74, 86) using a correction factor , 
which is derived from either simulation or phantom studies, to correct for average voxel 
value in a VOI for a given geometry.  This empirical partial volume compensation method 
can be expanded to correct for underestimation in DVH’ instead of the mean dose alone.  
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More advance partial volume correction methods use prior anatomical information 
based on co-registered high resolution CT images.  Application of this class of partial volume 
correction to 90Y quantitative PET imaging is very challenging because there is no biological 
uptake of microsphere distribution; microspheres are distributed mechanistically based on the 
blood flow in the vasculature, which may not be resolvable in CT images. 
We hypothesized that the dose-dependent systematic error originated from 
imperfection in random correction of bremsstrahlung photons.  Recently, 90Y-PET image 
reconstruction algorithms that model the prompt gamma have become clinically available.  
Similar phantom studies are needed to determine whether prompt-gamma modelling can 
reduce the dose-dependent systematic error in 90Y PET images. 
 
4.5.  Conclusion 
Low signal in 90Y PET imaging introduces both systematic and random errors in 
volumetric 90Y dose quantification.  Using errors in DVH’ as the objective function, the 
image reconstruction protocol can be optimized such the additional systematic error in DVH’ 
due to low signal < 10%.  To keep the random error low, 90Y PET data need to be acquired 
for as long as reasonably achievable (anti ALARA) duration, especially if motion correction 
is to be implemented. 
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Chapter 5: Effects of image noise, respiratory motion, and motion compensation on 3D 
activity quantification in count-limited PET images 
5.1. Introduction 
90Y microspheres are used for treating non-resectable primary and metastatic liver 
cancers (48, 49).  Post-treatment 90Y imaging is useful in assessing planned microsphere 
delivery and treatment efficacy (21, 81, 83, 87, 88).  Unlike most radionuclides used in 
nuclear medicine imaging, 90Y is effectively a pure beta emitter, i.e., it lacks discrete-energy 
photon emissions, such as gamma and/or characteristic fluorescence X-rays. As a result, 
imaging 90Y directly is challenging. The distribution of 90Y activity is traditionally assessed 
by imaging the bremsstrahlung photons—produced from interactions of energetic beta 
particles with soft tissue—using a gamma camera or single-photon emission computed 
tomography (SPECT)/computed tomography (CT).  The 90Y decay process has a very small 
branching to the excited state of stable 90Zr, which is followed by an internal pair production 
(~3.2 × 10−5 per β-decay) (50).  The positrons generate a pair of 511-keV annihilation 
photons that can be imaged using PET/CT.  Several recent studies have suggested that 90Y 
positron emission tomography (PET)/CT imaging is superior in image resolution, image 
contrast, and quantitative accuracy compared to 90Y bremsstrahlung SPECT/CT (24–26).   
Because liver is subject to respiratory motion, in vivo imaging of the liver is 
degraded by motion blur artifact.  Typically acquisition duration of 15–30 min/bed is used to 
compensate the extremely low 90Y-PET signal.  During the long PET acquisition, respiratory 
motion causes motion blur attributable to the time-averaging of multiple breathing cycles (a 
normal breathing cycle is typically 4 seconds).  Extensive studies of the impact of respiratory 
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motion in fludeoxyglucose (18F) (18FDG) PET have demonstrated that motion artifacts cause 
blurring of the target volume margins and underestimation of PET standardized uptake 
values (SUV) (41–44). 
Respiratory-gated PET/CT acquisitions group the acquired data into smaller phase 
or amplitude-matched bins to reduce motion blur, but at the cost of increasing noise, owing 
to the lower counts in each bin (46).  To simultaneously avoid this increase in noise and the 
potential for data misregistration (between the PET and CT images) that results from 
spatiotemporal mismatch (43, 89, 90), PET emission data can be acquired in a quiescent 
respiratory phase, such as end expiration, in which the motion is relatively low.  Quiescent-
period gating (QPG) was developed to allow free breathing acquisition while reducing the 
motion artifact (45). In high-count studies like 18FDG PET/CT imaging, it is clinically 
feasible to increase the acquisition duration (by a factor of 3 to 5 or, equivalently, by 10–15 
min) to compensate for the noise penalty from gating.  However, in a 90Y-PET/CT 
acquisition, in which the number of positron emissions is 0.033% of that of an equivalent 
18FDG scan, increasing the acquisition duration (for example, to 60–100 min/bed) to 
compensate for the noise penalty caused by respiratory binning is not practical. 
Previous work on PET motion compensation in 18FDG scans has compensated for 
underestimation in SUVmax or SUVmean; however, in these studies, the main imaging task was 
tumor detection, not measurement of the 3-dimensional (3D) activity or dose distribution. 
Post-90Y-microsphere therapy quantitative PET/CT imaging has been extensively researched 
over the past several years, but studies still focus on the mean activity concentration (AC), 
which is more relevant to diagnostic imaging than to post-therapy imaging (24, 66, 67, 91). 
Post-90Y-microsphere therapy PET/CT imaging provides the unique opportunity to make 
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voxel-level absorbed dose calculations that can subsequently be used to predict tumor control 
probability and toxicity to normal tissue, which will enable the development of more 
personalized and more effective treatment strategies. 
Drawing from radiation oncology, 3D voxel-level dosimetry calculation is often 
characterized by the cumulative dose volume histogram (DVH) (76, 77, 92, 93).  It has been 
suggested that the dose distribution in 90Y-microsphere therapy can readily be calculated 
from the 90Y activity distribution images by assuming local energy deposition of the 
electrons (35, 51).  Voxel-based dosimetry methods for 90Y-microsphere therapy have been 
developed recently (20, 34, 51, 94).  Those methods calculate the dose distributions from the 
3D AC distribution either from surrogate 99mTc-MAA SPECT/CT images or from 3D 90Y 
images (bremsstrahlung SPECT/CT or PET/CT) as the input functions.  One limitation of 
voxel-based dosimetry is the accuracy of the inputs, which are subject to image-degrading 
factors such as image noise and motion blur (40). 
The local deposition method assumes proportionality between absorbed dose to the 
voxel (in Gy) and activity concentration (in Bq/mL), which is the unit of voxels in PET 
images; therefore we propose to present DVHs as activity concentration volume histograms 
(ACVHs).  The ACHV plots the threshold AC (abscissa) against the fraction of the volume 
of interest (VOI) with AC greater than or equal to the threshold (ordinate).  ACVH also 
provides information about the conventional summary metrics, such as minimum, maximum, 
and median AC. The ordinate of ACVH spans 0% to 100% and the width of the ACVH curve 
around the median (50%) serves as an indicator of the non-uniformity of the 3D AC in the 
VOI; greater spread indicates a higher degree of non-uniformity.  We characterized the 
effects of image noise and motion blur on ACVH estimates in count-limited phantom studies 
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mimicking 90Y PET/CT images.  We also investigated whether the motion errors in the 
ACVH under very low-count conditions can be effectively compensated for using QPG. 
5.2.  Methods 
5.2.1. Data acquisition 
All PET/CT images were acquired using a GE Discovery 690 (General Electric 
Medical Systems, Milwaukee, WI). We assessed image quality and quantification using the 
National Electrical Manufacturers Association (NEMA) International Electrotechnical 
Commission (IEC) body phantom (Data Spectrum Corp., Chapel Hill, NC).  A small amount 
of 18F was injected into the IEC phantom as a surrogate radionuclide to simulate the inherent 
low count typical of 90Y PET/CT studies.  We matched the total number of positrons emitted 
in a 18F scan for 47 s/bed acquisition to those in a 90Y scan for 30 min/bed by equalizing the 
activity × positron yield × acquisition duration.  The typical 90Y scan emulated was for a 
mean liver dose of 30 Gy with tumor uptake ratio of 10 (22, 24). The IEC phantom was 
prepared with 18F AC in the background of 0.8 kBq/mL (equivalent to 600 kBq/mL for 90Y) 
and a sphere-to-background ratio (SBR) of 9.6. 
The PET data were acquired using a 1-bed position, centered at the spheres.  We 
only acquired CT images of a static phantom to calculate the attenuation correction.  We did 
not expect any significant motion errors in the attenuation map because both the spheres and 
background contain water, and the thin acrylic walls of the spheres have attenuation similar 
to that of water, at 511 keV. 
All images were reconstructed using 3D Ordered Subset Expectation Maximization 
(OSEM) iterative reconstruction with time-of-flight correction and point spread function 
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modeling (GE Vue Point FX-S) using the following parameters: 2 iterations and 24 subsets, 
50-cm field of view, 5.2-mm post-reconstruction axial filter, and standard z-axis filter. 
 
5.2.1.1. Effects of total count on 3D activity quantification 
To establish a high-count reference dataset, we acquired PET data of the 18F IEC 
phantom for 300 s (equivalent to a 3 hour/bed 90Y scan).  These data were down-sampled to 
shorter durations per bed position: 47 s (equivalent to clinical 90Y total counts, i.e., 100%), 
40 s (85%), 32 s (68%), 24 s (51%), 16 s (33%), and 8 s (17%).  Data down-sampling for 
each duration was done on 5 independent time windows to determine statistical variations in 
the activity distribution quantification. 
5.2.1.2. Effects of motion on 3D activity quantification 
To evaluate the effects of motion on activity quantification, we acquired 4 PET 
datasets with the IEC phantom: a single static reference acquisition and 3 motion-degraded 
PET data with periodic motions of 1-, 2-, and 4-cm amplitudes.  The phantom motion was 
tracked using a real-time position management device (RPM, Varian Medical System, Inc., 
Palo Alto, CA) (95).  We used an in-house motion platform (96) that uses a linear stage 
(Velmex, Inc., Bloomfield, NY) to simulate regular 1D respiratory patterns, with a typical 
period of 4 s and amplitudes of 1, 2, and 4 cm (Fig 22).  To reduce the compounding effect 
of image noise (section B.1.1), all PET data sets with motion were acquired for 300 s.  These 
300-s data sets had lower noise (background standard deviation [SD] of 15%) than do 
clinical 90Y PET images (background SD of 40%). 
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5.2.1.3. Effectiveness of QPG as compensation for 3D AC distribution in a count-
limited study 
We evaluated the ability of the QPG to effectively trade off motion blur and image 
noise in a count-limited PET study by improving the image contrast-to-noise ratio (CNR) and 
AC quantification. The 4 datasets acquired in section B.1.2 were down-sampled to 47 s to 
yield the total number of counts expected in a clinical 90Y PET scan.  The 3 motion-
degraded datasets were retrospectively binned into 3, 4, and 5 respiratory-phase gates over 
the 4-s motion period; the PET images were then reconstructed for each gate to create 4D 
PET images. 
The motion artifacts in the images were compensated using 2 QPG, with count 
(time) fractions of 25% and 33%, i.e., a single respiratory gate was used for image 
reconstruction from  4D PET that was gated with 4 and 3 respiratory bins, respectively. We 
also co-registered adjacent gated images (post-reconstruction) during the quiescent period to 
create QPG images with count fractions of 40% and 50%, i.e., to co-register 2 gated images 
in 4D PET with 5 and 4 bins (Fig 22), respectively. 
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 Fig 22.  The ilustration of the gating timing of quiescent period gating (QPG) motion 
compensation on 1-D motion input function with period of 4 s and amplitude of 1, 2, and 4 
cm.  QPG images with a count fraction of 25% were created by selecting 1 gated image in 
the quiescent period from a 4D PET image with 4 gates.  QPG images with a count fraction 
of 2 × 25% were created by co-registering 2 adjacent gated images in the quiescent period 
from 4D PET with 4 gates. 
 
5.2.2. Data analysis 
The hot spheres, which represented tumors, were segmented out using sphere VOIs 
contoured from the corresponding CT images (Fig 23).  The diameters of the VOIs were 
matched to the sphere diameters (from the NEMA IEC phantom manual) and were verified 
from the CT images of the sphere inserts.  For static PET images, all VOI locations were 
registered to the CT images of the spheres.  For PET images with motion blur, the VOI 
locations in the bed axis (along the motion direction) were manually adjusted by registering 
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the VOIs and the sphere location in the PET images; the centers of all VOIs were still co-
planar. 
The normal liver tissue surrounding the tumor was represented by a 126-mL 
cylinder containing a 1.7-cm sphere (Fig 23).  The spherical VOI (diameter of 1.7 cm) was 
segmented out from the cylindrical VOI to simulate uniform 90Y activity in normal tissue 
around the tumor. 
 
Fig 23.  Size and placement of the volumes of interest (VOIs) from which activity 
concentration distributions were quantified.  The spherical and cylindrical VOIs represent, 
respectively, tumors and normal tissue surrounding the 17-mm “tumor” in transaxial (A) and 
coronal (B) views. 
 
To quantify the AC distribution, we calculated the cumulative ACVH for all VOIs 
(6 spheres and 1 background) for the 4 PET image acquisitions.  In addition, we calculated 
the ACVHs for each down-sampling and gating method. 
 
5.2.2.1. Effects of total count on 3D activity quantification 
The ACVHs of both the sphere and the background were calculated for all static 
PET images with durations of 300 s (reference images), 47 s, 40 s, 32 s, 24 s, 16 s, and 8 s.  
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The ACVHs for 47, 40, and 32 s images were calculated as the average ACVH from 5 down-
sampled scans; whereas the ACVH for 24, 16, and 8 s were calculated as the average of 10 
down-sample scans.  The variability of the ACVH was measured as the standard deviation of 
multiple down-sampled scans of the same total duration.  The ACVH for each down-sampled 
image was compared graphically against those for the reference images.  The ACVHs were 
compared quantitatively by computing the deviation of the AC of the PET images from that 
of the reference image as a function of cumulative volume. 
For the spheres, we also reported the difference in mean AC (ACmean) and 
differences in ACX (defined as the minimum AC that covers X% of the VOI) that are 
typically used in tumor dosimetry; for example, AC90, AC80, and AC50 as a function of total 
count (or duration).  The relationship between the ACVH parameters AC90, AC80, AC50, and 
ACmean and the count densities was evaluated using linear regression analysis; the slopes and 
the corresponding p value were reported. 
 
5.2.2.2. Effects of motion on 3D activity quantification 
We visually analyzed the effects of motion in the sphere images by comparing the 
motion-degraded images with the static reference images.  We also compared line profiles of 
the sphere images along the motion direction as a semi-quantitative analysis of the motion 
blur. 
The ACVHs of both the sphere and background were calculated for all high-count 
static (reference) images and high-count motion-degraded PET images.  The ACVH for the 
motion-degraded images was compared graphically against the ACVH for the static 
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reference images.  The ACVH values were also compared quantitatively by computing the 
errors in AC of the motion-degraded images with respect to the reference static image as a 
function of cumulative volume. 
In addition, for sphere images, we used linear regression analysis to evaluate the 
relationship between the errors in ACmean and the relative motion (motion amplitude/sphere 
diameter) for 5 sphere diameters (37, 28, 22, 17, and 13 mm).1 The Pearson correlation 
coefficient and the p value were reported. 
 
5.2.2.3. Effectiveness of QPG to compensate for motion errors in 3D AC distribution in 
count-limited PET images 
We evaluated the effectiveness of motion compensation using QPG with count 
fractions of 25% and 33% by quantifying the relative change (with respect to the static 
reference images) in image CNR and AC with and without QPG. 
The effectiveness of motion compensation in the sphere images was visually 
analyzed by comparing the in-motion images with and without motion compensation to the 
static reference images.  The CNR of the spheres was also calculated, as (sphere ACmean – 
background ACmean) / (background SD of mean), to evaluate the improvement in the image 
contrast. 
The ACVHs of both the sphere and the background were calculated for static 
reference images and in-motion PET images with and without motion compensation.  The 
ACVH of the in-motion images was compared graphically against the ACVH of the static 
1 The 10-mm sphere in IEC phantom was not detectable due to the very high noise, so the 13-mm sphere was 
the detection limit. 
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reference images.  We also quantitatively compared the ACVHs by computing the errors in 
AC of the in-motion images before and after motion compensation.  All errors were reported 
as differences from the static reference images. 
For the reconstructed sphere images, we used linear regression analysis to evaluate 
the relationship between ACmean and relative motion before and after motion compensation 
for 5 sphere diameters at 3 different motion amplitudes. The significance of the differences in 
the slopes of the linear regression curves before and after motion compensation were 
evaluated using a 1-sided t-test. 
 
5.3.  Results 
5.3.1 Effects of total count on 3D activity quantification 
Reducing the acquisition duration resulted in an increase in the image noise, as 
shown in Fig 24A.  The range of observed AC increased with lower acquisition duration, i.e., 
the measured minimum AC decreased while the maximum AC increased (Fig 24B and Fig 
24C).  The increase in the non-uniformity of the AC distribution was more pronounced in the 
smaller spheres, i.e., the change in the ACVH spread was greater for the 17-mm sphere than 
for the 37-mm sphere.  Because of the lower AC in the background (SBR of 9.6), the 
increase in AC distribution inhomogeneity was higher in the background region, as shown in 
the images in Fig 24A and the ACVHs in Fig 24C. The observed profiles were substantially 
different that the ideal ACVH, in part, due to the partial volume effect; the differences from 
ideal were less pronounced in the background compared to the tumor VOI (Figures 3B and 
3C). 
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 Fig 24. (A) Transaxial PET images of an IEC phantom acquired for the indicated durations.  
The window width and level of these images were adjusted manually to show the texture of 
the sphere images. (B, C) Activity concentration volume histograms (ACVH) for (B) the 17-
mm sphere and (C) the surrounding background region as the acquisition duration varied.  
Note: the gray dashed ACVHs show ideal ACVH calculated from known activity assays.  
The ACVHs in (B) and (C) were average ACVH from multiple down-sampled scans.  
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 AC20 to AC40 was observed to be less sensitive to duration reduction (< 10% 
deviation from the low-noise reference), as shown in Fig 25A.  At an acquisition duration of 
32 s (68%), the ACVH errors were comparable to the errors (< 5% difference) at the 47-s 
acquisition (100%), except beyond AC90.  At acquisition duration of 8 s (17%), the errors 
were > 10% outside the AC20 to AC40.  Fig 25B shows the ACVH errors as a function of 
acquisition durations for several ACX that are typically used in tumor dosimetry.  The errors 
and variability of ACmean were independent of a reduction in acquisition duration down to 
17%.  The slope of ACmean versus the acquisition duration was statistically consistent with 
zero; while the slopes for other ACX were non-zero and statistically significant (p < 0.05).  
The magnitude of both ACX errors and ACX variability monotonically increased away from 
ACmean (at around AC30) toward both extremes, i.e., AC0 (ACmax) and AC100 (ACmin).  The 
variability of ACX was also affected by the object and VOI sizes; the SD for the 37-mm 
sphere was smaller than it was for the 17-mm sphere.  Similar trends were observed for 
ACVH parameters in the background VOIs. 
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Fig 25.  (A) Errors in the 17-mm sphere activity concentration volume histogram (ACVH) 
with respect to the ACVH calculated from reference images for multiple acquisition 
durations.  (B) Errors of activity concentration (AC) parameters that are typically used in 
tumor dosimetry as a function of acquisition duration for the 17-mm sphere.  The error bars 
represent ± 1 standard deviation. 
 
5.3.2. Effects of respiratory motion on 3D activity quantification 
Motion blurred the activity distribution of the spheres across a volume larger than 
the actual sphere diameter, causing underestimation of the actual sphere AC and an increase 
in the surrounding background AC, as shown in the sphere images and their line profiles in 
Fig 26.  The magnitude of the underestimation depended on the relative motion amplitude 
with respect to the sphere diameter. 
 
Fig 26.  (A) Coronal PET images showing the motion blurring artifact from the breathing 
pattern (shown in Figure 1) on 37- and 17-mm spheres.  Z line profiles of 37-mm (B) and 17-
mm (C) spheres extracted from the PET images (location shown by the dashed blue lines in 
[A]). 
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The ACVHs for the spheres and the background regions under 1-, 2-, and 4-cm 
motion patterns are shown in Fig 27A and Fig 27B, respectively.  The average errors 
(relative to the static case) in sphere ACmean were −4%, −16%, and −52% for the 37-mm 
sphere under 1, 2, and 4-cm motion amplitudes, respectively; these errors increased to −6%, 
−27%, and −64% for the 17-mm sphere.  The maximum AC (AC0), however, was not 
underestimated if the relative motion was < 1, as shown in Fig 27.  The errors in the other 
ACX values, AC90, AC80, and AC50, followed a similar pattern as that of ACmean; the variation 
in errors for these parameters was about 10% from the ACmean. 
The ACVH was relatively unchanged by 1-cm motion for the 37-mm sphere but 
showed more substantial underestimation for the 1.7-cm sphere with the same 1-cm motion 
(Fig 27A).  The error magnitude of ACmean depended on the relative motion; the Pearson 
correlation coefficient of the error in ACmean against the relative motion was 0.90 (p << 
0.001).  At small relative motion values (≤ 0.5 cm), the errors in ACmean due to motion blur 
were small (≤ 5%). 
Fig 27B illustrates the increase of AC (about AC30 to AC10) in the region 
surrounding the 17-mm sphere.  The increase was higher for wider motion amplitudes.  
Nevertheless, the ACVH errors in the background region that were attributable to motion 
were minimal.  For 4-cm motion blur, the ACVH errors were < 10% at AC10 to AC80 because 
the motion blur covered only a small fraction (< 5%) of the background region VOI. 
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 Fig 27.  Cumulative volume histograms from volumes of interest in (A) the 17-mm sphere 
and (B) background regions under the static reference condition and motion with 1-, 2-, and 
4-cm amplitudes. 
 
5.3.3. Effectiveness of QPG to compensate for motion errors in 3D AC distribution in 
count-limited PET images 
QPG (with various count fractions) reduced the severity of motion blur.  As shown 
in Fig 28A, the narrower the QPG gate width, the greater the reduction in motion blur. The 
17-mm sphere images (with 4-cm motion amplitude) that were compensated using QPG with 
a count fraction of 25% had less motion blur than those compensated using QPG with a count 
fraction of 33%.  Narrower gate widths, however, had smaller total counts, which led to an 
increase in image noise and consequently an increase in image non-uniformity, as is evident 
from the stretch in the ACVH of the motion-compensated images (Fig 28B, C for the 17-mm 
sphere and Fig 28D, E for the surrounding background region).  The increase in non-
uniformity from QPG was consistent with the increase in non-uniformity from reduced 
acquisition duration (Fig 28).  This trade-off between motion blur reduction and increase in 
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image noise is apparent from the CNRs of the 17-mm sphere images under various 
conditions (Fig 28A). 
 
Fig 28.  (A) Images of the 17-mm sphere under the static condition and with the 4-cm motion 
amplitude without and with quiescent period gating (QPG) with various count fractions. The 
contrast-to-noise ratio (CNR) of the 17-mm sphere is shown.  (B, D) Activity concentration 
volume histogram of (B) the 17-mm sphere and (D) the surrounding background region.  (C, 
E) Error in activity concentration coverage with respect to the static condition as a function 
of cumulative volume for the 17-mm sphere (C) and the background region (E). 
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The average errors in AC10 to AC80 were reduced from −25% and −55% to −10% 
and −15% for sphere images degraded by motion with amplitudes of 2 cm and 4 cm, 
respectively.  Similarly, the underestimation of the ACmean of the 1.7-cm sphere was reduced 
from ~30% and ~50%, respectively, to ~10% for both 2-cm and 4-cm motion.  Fig 29 
shows the errors in ACmean before and after QPG (2 × 20%) as a function of relative motion 
for all sphere images (37–13 mm) under the 3 motion patterns evaluated (amplitudes of 1, 2, 
and 4 cm).  The t-test indicated that the difference in the slopes before and after QPG was 
significant (p = 0.029).  With QPG, the errors in ACmean (with respect to the low-noise 
image) were reduced to about 10%, regardless of the relative motion.  The QPG reduced the 
motion blur errors at all AC levels.  AC40 to AC60, however, suffered from errors attributable 
to increased noise. 
 
Fig 29.  Errors in mean activity concentration (ACmean) as a function of relative motion 
(motion amplitude/sphere diameter) for sphere images (37–13 mm) under 3 motion patterns 
(amplitude of 1, 2, and 4 cm) with and without motion compensation. 
101 
 
ACVH  for the background region has reduced counts fractions following QPG, the 
errors in the ACVH after QPG were dominated by the reduction in counts.  The motion 
errors in all cases were < 10% for AC10 to AC80.  
5.4. Discussion 
5.4.1. Bias and variability in AC quantification 
At the typical level of total count realized in clinical settings for 90Y PET with 30 
min/bed, the overall errors from both bias and variability in the static case (with no 
respiratory motion) for AC90 and AC80 were within 10% (Fig 25).  In realistic scenarios with 
respiratory motion, when QPG motion compensation was used, the total count decreased to 
about 30%, and the expected overall error in AC90 and AC80 was > 50%.  In this case, AC50 
and ACmean were less sensitive to the total count reduction.  Dose-response studies of both 
brachytherapy (70) and other radiopharmaceutical therapies, such as 131I (29) and 177Lu (97), 
have suggested a strong correlation between AC90 (or AC80) and tumor response metrics. 
Furthermore, these studies also demonstrated that ACmean (or AC50) was not significantly 
correlated with tumor response.  AC60–AC80, which may be more relevant to tumor 
dosimetry, had errors of about −15% at an acquisition duration of 16 s (33%) or 10 min/bed 
for 90Y PET.  
It is noteworthy that in this study, the 100% sphere total count represents a tumor 
with an AC of 6 MBq/mL acquired for 30 min/bed.  (24)(2013) found that tumor AC ranged 
from 2000 to 13000 kBq/mL.  Assuming a local deposition method (35, 51) to convert the 
AC map to the dose map, an AC of 6 MBq/mL would result in a tumor dose of 290 Gy, 
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which is in agreement with the finding from (22) (2013).  Depending on the actual tumor AC 
and the acquisition duration, the overall errors may vary. 
 
5.4.2. Effectiveness of QPG to compensate for motion errors in 3D AC distribution in 
count-limited PET images 
QPG shows potential for reducing errors in ACVH in quantitative 90Y PET/CT 
studies that suffer from motion blur.  Qualitatively, a single-gate QPG, e.g., QPG 25% or 
QPG 33%, did not show improvement in sphere detectability (measured using CNR).  
Although the sphere image showed a reduction in motion blur, it also displayed increased 
noise (Fig 30A).  Quantitatively, sphere images with QPG motion compensation  improved 
ACVH over uncorrected ACVH, i.e., the compensated ACVH was closer to the static 
ACVH. 
As shown in Fig 30 the total counts limit the effectiveness of QPG.  After QPG with 
a count fraction of 33%, the compensated ACVH of the 17-mm sphere under both 2-cm and 
4-cm motion agreed with that of the ACVH of static images with a 33% total count.  A noise-
related error of 15% in AC60–AC80 for the 17-mm sphere image acquired for 16 s was also 
achievable after QPG with similar image noise (Fig 30B).  For tumors with relative motion ≥ 
0.5, QPG with various count fractions can be applied to reduce the errors in ACVH.  
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 Fig 30.  (A) Activity concentration volume histogram (ACVH) of the 17-mm sphere under 
static condition, with motion without correction, and with quiescent period gating (QPG) 
motion compensation (33% count fraction). (B) Differences in the ACVH curves in (A) with 
respect to static ACVH (100% total count) as a function of cumulative volume.  Note: figure 
legend in (A) and (B) are the same. 
 
Registration of 2 adjacent gated images during the quiescent period increases the 
total count and reduces noise.  However, gated images acquired during the quiescent period 
may not be completely motionless, depending on the breathing motion pattern.  The images 
may also have different residual motion, as shown in Fig 28.  For instance, QPG 25% will 
have less motion blur than QPG 2 × 25%. Consequently, the sphere CNR of QPG 2 × 25% is 
comparable to that of QPG 25%, as illustrated in Fig 28A. 
Optimizing the trade-off between the motion blur reduction and the increased noise 
is beyond the scope of this study, as such optimizations strongly depend on the specific 
imaging conditions and imaging tasks; therefore, optimization needs to be performed on a 
case-by-case basis.  As an example, for the 17-mm sphere, QPG 25% reduced the errors in 
ACVH better than QPG 2 × 25% did for 2-cm motion. However, for 4-cm motion, QPG 2 × 
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25% yielded lower ACVH errors than did QPG 25%, although the sphere CNR was 
comparable (Fig 28A).  Another practical consideration is that in clinical settings, deformable 
image registration may be required, and misregistration errors will produce errors in AC 
quantification (45, 89, 98).  In addition, the errors in the ACVH of the background region are 
dominated by the errors from noise; the errors due to motion were < 10%.  Our results 
suggest, therefore, that the QPG method is not effective for motion compensation in the 
background region (Fig 28D and Fig 28E). 
Our data show that QPG need not be applied to tumors with relative motion < 0.5, 
i.e., with motion amplitude half of the tumor size.  Applying QPG in such cases results in an 
error in ACmean of about 10% (Fig 29).  In these cases, the errors in activity quantification 
introduced by motion are of the same order as, if not smaller than, the errors introduced by 
the reduced total count.  In a real clinical case, respiratory motion is the largest in the 
superior-inferior direction, with a typical amplitude of about 2 cm.  By comparison, 
hepatocellular carcinoma tumors are typically > 2 cm, while metastatic liver tumors from 
colorectal cancer are typically < 1 cm. 
 
5.4.3. Study limitations 
Although the specific count-limited study of interest is 90Y PET images, we used 
low amount of 18F after careful matching of the total positron emissions to evaluate the 
noise trade-off of using QPG to compensate for respiratory motion.  Furthermore, we do not 
expect substantial differences in intrinsic image resolution because the maximum positron 
energies of 18F and 90Y are very close (0.635 MeV vs. 0.63 MeV, respectively) (25, 99).  
The overall image quality, however, may be somewhat different because random 
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coincidence event from bremsstrahlung photon and prompt gamma detection may not be 
modeled properly in 90Y-PET image reconstruction, which is optimized for 18F imaging (27, 
100). 
Second, we used an IEC phantom, which has uniform activity distribution in both 
spheres and background, to represent tumor tissue and normal liver tissue.  In reality, the 
geometry and activity distributions in tumors and normal liver background are not 
necessarily homogeneous.  Further studies using anthropomorphic phantoms and/or clinical 
90Y PET/CT studies are needed to evaluate the effectiveness of QPG for motion 
compensation and to determine the optimal count fraction for use in clinical studies.  Our 
study also used a single SBR of 10, which is typical for the 90Y-microsphere tumor-to-
background ratio reported by some PET/CT clinical studies (24).  We expect that changes in 
SBR will change the magnitude of the observed phenomena, but will not change the general 
trend. 
Third, we only considered 1D periodic motions with a period of 4 s and fixed 
amplitudes of 1, 2, and 4 cm because of tracking device hardware limitations.  Irregular 
motions may introduce additional uncertainty in AC quantification (42, 43, 90).  We expect 
that different periods, however, will only change the relative motion range in the gated 
images. 
Fourth, we did not correct for partial volume effects beyond using the built-in point 
spread function correction in GE VuePoint.  However, we excluded partial volume effects as 
a potential source of error by using the reference static images. 
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Finally, we only considered the QPG single-gate and double-gate summation 
regimes.  Motion correction techniques that avoid increasing acquisition duration are under 
development, including pre-reconstruction corrections that use data-driven approaches and 
motion corrections for use during image reconstruction (101).  These methods, however, are 
not yet commercially available for clinical use.  It would be valuable to evaluate whether 
these data-driven correction methods will benefit count-starved 90Y PET studies as much as 
they do high-count 18F studies. 
5.5. Conclusion 
Caution needs to be exercised when using ACVH parameters such as AC90 and 
AC80 to calculate absorbed dose because the ACVH is susceptible to image degradation from 
both image noise and respiratory motion.   When using gating-based motion compensation, 
e.g., the QPG method studied here, with 33% total count in the gated image, the overall error 
(bias and variability) in AC90 and AC80 can be over 60%.  The ACmean seems to be less 
sensitive to image noise, but its correlation with clinical response to radiation therapy has not 
yet been established. 
The average error in sphere ACVH (from AC10 to AC80) with relative motion 
(motion amplitude/sphere diameter) less than about 0.5 was found to be < 10%.  QPG can be 
used to reduce motion blur artifacts and reduce the errors in sphere ACVH down to 10–15% 
(limited by the total count acquired), but at the expense of increased image noise.  QPG was 
found to be ineffective for the quantification of background AC distribution. 
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Chapter 6: Discussion 
6.1. Summary 
 The hypothesis of this dissertation work was that optimization of Y90 emission 
data reconstruction can maintain the overall errors (systematic and random) in volumetric 
dose quantification to < 20% in clinically relevant imaging conditions 
Hence the main objectives were 1) to optimize the emission data reconstruction, and 
2) to characterize both systematic and random errors in volumetric dose quantification from 
the optimized emission images. 
We tested the hypothesis on both SPECT in specific aim 1 (Chapter 2) and on PET 
in specific aim 2–4 (Chapter 3–5) images. 
We developed a practical protocol for improving image quality and quantification 
of bremsstrahlung SPECT/CT (bSPECT) imaging in specific aim 1.  We found severe partial 
volume effect (PVE), where the systematic bias in mean dose of 37-mm sphere > 50%, due 
to electron staggering in bremsstrahlung photon production and sub-optimal collimator 
design to image bremsstrahlung photons.  Because of high systematic errors due to PVE, 
volumetric dosimetry using bSPECT is very challenging; Monte-Carlo simulation based 
image reconstruction and/or a bSPECT-optimized hardware design are needed to improve the 
image resolution.  Nevertheless, we have shown that with proposed CT attenuation correction 
and background compensation, we can accurately quantify the total 90Y activity delivered to 
the patient with errors < 5%. 
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In specific aim 2, we optimized PET image reconstruction parameters (equivalent 
iterations and filtration full width at half maximum) for volumetric 90Y dosimetry by 
minimizing the root mean square errors in the image-based dose volume histogram estimates 
(DVH’).  In the process, we also minimized the systematic error in the quantitative 
image/dose map due to noise realization in image noise.  For ordered subset expectation 
maximization with time of flight and point spread function correction algorithm in General 
Electric PET/CT system, the optimal reconstruction parameters were 36 equivalent iterations 
with 5.2-mm post-reconstruction filtration.  Using these parameters, spheres under various 
clinically relevant imaging condition (diameter > 17 mm, sphere-to-background ratio > 4, 
sphere dose > 40 Gy, acquisition duration > 10 min) were found to have minimum errors in 
DVH’. 
The systematic and random errors in DVH’ were characterized in specific aim 3 and 
4.  In specific aim 3, we showed that the (additional) systematic errors due to image noise 
(manifestation of low signal) were < 10% for clinically relevant imaging condition tested.  
The systematic errors in DVH’ were still dominated by the PVE (> 30%), even at count-
limited study 90Y PET.  The random errors (measurement repeatability), however, were 
governed solely by the low signal.  Random errors of < 10% can be expected in DVH’ of 
sphere images under relevant clinically imaging condition, provided that the acquisition 
duration of 30 min.  Under shorter acquisition duration (e.g. 10 min) or if gating-based 
motion compensation method (e.g. quiescent period gating) is applied, then sphere with 
diameter ~17 mm will have random errors of > 15%; even though larger sphere (e.g. 37-mm 
sphere) will still have random errors < 10% at sphere dose> 80 Gy.  To keep random errors < 
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10–15%, longer acquisition duration is required; in clinical practice, the maximum practical 
limitation will likely be 30 min/bed for 2 bed positions (60 min total duration). 
In specific aim 4, we characterized a specific source of systematic errors, namely 
motion blur.  We found that without any motion compensation, spheres with relative motion 
range (motion amplitude/sphere diameter) > 0.5, errors in DVH’ > 20%.  Using gating-based 
motion compensation (QPE method), we traded off the systematic errors due to motion with 
a combination of systematic and random errors due to low signal (from gated data).  
Although we have shown that the systematic errors due to motion blur can be reduced to 
<10%—which is consistent with systematic errors due to increased image noise found in 
specific aim 3—the random errors increase due to data gating with magnitude depending on 
the sphere diameter and acquisition duration such that spheres with motion range < 0.5 will 
not benefit from QPG and spheres with motion range > 1 will likely benefit from QPG.  The 
total errors reduction using QPG will vary on case-by-case basis; hence it would be 
recommended that motion tracking is performed on all 90Y PET scan such that the QPG 
method can be applied when deemed necessary. 
Our finding from development of practical bSPECT did not support our central 
hypothesis since bSPECT images suffer from very high PVE even at 37-mm sphere.  
Volumetric dosimetry using bSPECT will suffer errors >> 50%.  Data from specific aim 2–4, 
on using optimized PET images to estimate DVH’, support the central hypothesis under 
certain imaging condition: effective tumor diameter > 37 mm, average tumor dose > 60 Gy, 
acquisition duration > 10 min.  Under this imaging condition, the errors in dose that covers 
80% of the volume of interest are < 30%.  The errors in Dmean and D70 are < 20%. 
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 6.2. Listed contributions of this dissertation 
6.2.1. Physics contributions 
1) Characterization of the impact of low count (a unique challenge in 90Y PET) on systematic 
and random errors in volumetric dosimetry. 
2) Characterization of the impact of motion blur and the effectiveness of QPG in trading-off 
motion blur and reduced count in an already count-limited 90Y PET study. 
3) Establishing the expected errors (systematic and random) in image-based dose volume 
histogram. 
6.2.2. Clinical contributions 
1) Development of practical bSPECT image reconstruction for improved image quality and 
limited quantification. 
2) Development of practical PET/CT image reconstruction for volumetric 90Y dosimetry. 
3) Establishing the robustness of the dosimetry metric (DVH’ summary metrics) which is 
important in developing dose-response model. 
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6.3. Future directions 
6.3.1. Continuation to minimize errors in volumetric 90Y dose quantification 
6.3.1.1.  Robustness of volumetric 90Y dosimetry in heterogeneous distribution 
One of the major limitations in our present work is that we represent liver tumor 
using spheres with uniformly distributed 90Y dose.  In reality, the 90Y dose distribution in the 
tumor is heterogeneous, which increases the complexity of correcting DVH’ for PVE, dose-
dependent error, etc.  In the future, we plan to characterize the errors in DVH’ for (pseudo) 
heterogeneous distribution, for example by using a cluster of smaller spheres. 
 
6.3.1.2. Partial volume correction 
We have shown that despite having very limited counts, the errors in volumetric 90Y 
dosimetry calculated from both bSPECT and PET images are still dominated by PVE; 
therefore effort to improve volumetric 90Y dosimetry should first focus on partial volume 
correction. 
In our present work, we used the point-spread-function (PSF) correction available 
on GE OSEM algorithm (Vue Point).  While the errors in mean dose (Dmean) are reasonable 
(< 10% for 37-mm sphere), the errors toward minimum dose (e.g. D80) are > 30% for 37-mm 
sphere with minimal systematic errors due to image noise.  Traditionally for quantitative 
diagnostic imaging, where Dmean is the quantity of interest, partial volume correction can be 
carried empirically using look-up correction factors for different object sizes based on 
phantom studies.  In post-therapy 90Y imaging, however, the summary DVH’ metric of 
interest has not yet been determine and hence we remain interested in a wide range of DVH’ 
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metrics (e.g. D20–D80).  We hypothesize that the empirical partial volume correction method 
to correct for Dmean, can be extended to correct for DVH’ by using correction functions, 
which is subject to our future study. 
More complicated partial-volume-correction methods that involve the use of prior 
image information (e.g. CT or MRI images) can be very challenging to be applied for 90Y 
microsphere studies; the mechanistic nature of microsphere distribution means that the 
distribution of microsphere is not confined to the tumors only.  The microsphere distribution 
needs to be match with the vasculature which may not be resolveable in the CT or MR 
images, or otherwise may not be feasible to co-register the anatomical images with the PET 
or SPECT images. 
 
6.3.1.3. Breathing motion correction 
90Y PET data needs to be acquired for a long duration, 30 min/bed at least because 
the signal in 90Y PET comes from a very low positron yield of 32 ppm.  The number of 
counts in 90Y PET data is a scarce commodity.  In QPG method, however, we used only 33% 
of the counts collected, which leads to increase in both systematic and random errors in 
volumetric 90Y dosimetry. 
Ideally in 90Y-PET/CT study, we want to reconstruct the PET images using all the 
acquired data by combining the gated data during image reconstruction(89, 102)  or by 
spatially registering all (post reconstruction) gated images(103, 104) together.  The latter may 
not be feasible in 90Y PET because gated PET images suffers from errors due to higher noise 
penalty(89), while gated CT are subject to temporal mismatch (43, 90) between several 
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seconds CT data with up to 60 min PET data.  Combining the gated data during image 
reconstruction using motion pattern from real-time position management device or data-
driven method may allow more effective error reduction in DVH’ compared to QPG method. 
 
6.3.1.3. Development of dose-response model to predict treatment outcome 
The long term goal of this project is to be able to predict the efficacy of 90Y 
microsphere therapy based on the post-therapy images.  To achieve this goal, we need to 
develop a dose-response model.  In this dissertation work, we characterized the robustness of 
potential dose metrics (e.g. D70 or Dmean that have been used by other studies) that may have 
(strong) correlation with tumor response.  Evaluation of which dose metrics have strong 
correlation with tumor response cannot be done with our phantom study, since development 
of dose-response model, obviously, need the tumor response data, i.e., clinical data, which 
are absent in this dissertation work.  In the future, we would like to develop the dose-
response model by correlating dose metrics with patient outcome. 
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Appendix 
A1. Evaluation of Step-and-Shoot and Continuous-Bed-Motion modes of acquisition 
for limited-view organ scans 
A.1.1.  Introduction 
The continuous-bed-motion (CBM) mode was originally developed to improve 
axial image uniformity in whole body imaging in 2D step-and shoot (SS) acquisition 
mode(105), where there were sensitivity variations in the axial direction due to gaps between 
detector blocks(106).  The axial uniformity, however, is no longer a problem in modern 
PET/CT scanners utilizing 3D SS acquisition mode, where the axial uniformity in 3D 
acquisition can be improved by overlapping the end slices of adjacent bed positions and 
adding the overlapped data(107).  Theoretically, CBM mode may also allow oversampling in 
the z-axis direction and produce super-resolution images(108); however, this super-resolution 
effect is not realized in clinical practice due to high level of noise(106). 
The true clinical benefit of CBM is the ability to tailor fit the PET/CT scan length 
and local scan duration based on the imaging task.  In traditionally SS mode, the PET scan 
length increases in steps of the PET z-axis field of view (aFOV) depending on the amount of 
detector overlap between bed positions.  Hence, the ability to tailor fit the PET/CT scan 
length allows modest CT dose saving and facilitates trading off the scan length with the total 
scan duration.  In multi-bed SS acquisitions, the PET acquisition duration per bed is also 
fixed; whereas in CBM mode, the local acquisition duration can be modulated along the z-
axis adjusted by varying the bed speed; hence allowing acquisition of higher counts in 
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regions of greater interest.  In addition, clinical practice has also suggested that patients find 
CBM more comfortable compared to SS acquisition(109). 
Recently, the CBM acquisition mode has been made commercially available in 
Siemens Biograph mCT Flow (Siemens Medical Solutions USA, Knoxville, TN).  The CBM 
acquisition mode is intended for whole body PET/CT imaging with long scan length 
(multiple aFOVs).  The benefits of CBM mode in clinical whole body imaging have been 
studied(106, 110).  The benefits of CBM acquisition mode in short scan length studies, 
however, have not been investigated.  The objective of this work is to evaluate the potential 
differences in the counting efficiency profiles along the z-axis between CBM and SS modes 
of acquisition for limited-view organ studies, such as 90Y PET/CT liver scan, where the scan 
length is short (≤ 2 aFOV) and the scan duration is long(28, 111) (≤ 30 𝑚𝑖𝑛/𝑏𝑒𝑑).  We also 
discuss the implication of these differences on the image quality and quantification of 90Y-
PET/CT liver scan. 
A.1.2.  Methods 
A.1.2.1. Analytical comparison of counting efficiency in CBM and SS modes 
A.1.2.1.1.Counting efficiency profiles in 3D SS acquisition mode 
The sensitivity (count rate per unit activity) profile of PET acquisition is 
proportional to the volume of response (VOR) accepted for a given geometry(112).  In 3D SS 
acquisition mode, the VOR at any given axial position along the PET bed is proportional to 
its distance from the edge of the aFOV, i.e., the VOR is the largest at the center and the 
smallest at the edges of the aFOV (Fig 31A).  The 3D SS acquisition therefore has a 
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triangular sensitivity profile for scan length of 1 aFOV (Fig 31B).  For multi-aFOV SS 
acquisition, the overall sensitivity profiles can be calculated by adding the count profiles of 
each individual aFOV acquisitions accounting for the amount of bed overlap (Fig 31C).  In 
reality, the axial sensitivity profile is not exactly triangular but has a saw-tooth shape with a 
plateau depending on the axial compression that is used on the scanner , the maximum 
acceptance angle, and the number of detectors used.  An ideal simplification of sensitivity 
profile is used to conceptually illustrate sensitivity/bed overlap in 3D SS modes. 
 
 
Fig 31. (A) Volume of response (VOR) in 3D step-and-shoot (SS) acquisition at two 
locations: a and b. The VOR varies linearly as a function of distance along the axial (z-axis) 
field of view (aFOV).  (B) For a single aFOV, the VOR and the sensitivity as a function of 
position has a triangular profile.  (C) For two-aFOV SS acquisition, the VOR profile as a 
function of position is simply a summation of the individual aFOV profiles at each bed 
position taking into account the amount of bed-overlap; 43% aFOV overlap in Siemens mCT 
is illustrated. 
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The number of counts in an image slice is proportional to the integral of its VOR 
over time.  For a uniformly distributed activity along the bed motion direction (z axis), the z-
axis count profile 𝐶(𝑧) can be calculated as 
𝐶(𝑧) ∝ � 𝑉𝑂𝑅(𝑧)𝑑𝑡𝑡𝑑𝑢𝑟
0
= 𝑉𝑂𝑅(𝑧) × 𝑡𝑑𝑢𝑟  ,   
(1) 
where 𝑉𝑂𝑅(𝑧) is the volume of response at slice 𝑧 and 𝑡𝑑𝑢𝑟 is the acquisition 
duration.  In SS mode, the VOR varies only as a function of location inside the aFOV; hence 
the count profile is proportional to the VOR. 
 
A.1.2.1.2.Counting efficiency profiles in CBM mode 
In CBM mode, the object is moving along the z-axis; hence during the acquisition, 
the VOR for slice location z changes over time.  The variation of the VOR at location z as a 
function of time, 𝐶𝑧(𝑡), is illustrated in Fig 32.  For Siemens mCT scanner, the CBM mode is 
acquired with 50% overscan, i.e., the scan prescription begins and ends at the center of the 
detector aFOV(106).  In this configuration, the count profile for a uniform cylindrical source 
consists of 1/2-aFOV-long ramp up and down regions at the beginning and end with a flat 
constant profile in between (Fig 32C).  Following equation (1), the count profile for CBM 
can be expressed as: 
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𝐶(𝑧) ∝ − 𝑧22𝐿𝑣 + 𝑧𝑣 + 𝐿2𝑣                       ,𝑓𝑜𝑟 0 ≤ 𝑧 ≤ 𝐿, 
𝐶(𝑧) ∝ 𝐿
𝑣
                                                 ,𝑓𝑜𝑟 𝐿 ≤ 𝑧 ≤ 𝐿 + 𝑑, 
𝐶(𝑧) ∝ − 𝑧′22𝐿𝑣 + 𝑧′𝑣 + 𝐿2𝑣                      ,𝑓𝑜𝑟 𝐿 + 𝑑 ≤ 𝑧 ≤ 2𝐿 + 𝑑, 
  
 
(2) 
where 𝑧 is the image slice position along z-axis, 𝐿 is half of the FOV length, 𝑑 is 
the length of the uniform region, 𝑣 is the bed speed, and 𝑧′ = −(𝑧 − 2𝐿 − 𝑑). Note that 𝑑 is 
equal to the total scan length minus 2𝐿.  In reality, the actual efficiency profile depends on a 
large number of hardware and software parameters that include the detector segments used 
and the scan extend outside the aFOV.  We have once again simplified the theoretical 
derivation of the axial efficiency to conceptually illustrate the sensitivity profile in CBM 
mode.  
The PET and the CT acquisition have a matching scan length prescription, which 
does not account for the 50% overscan in PET acquisition.  Due to the missing CT-based 
attenuation correction factors outside the PET/CT scan prescription, the coincidence counts 
acquired in the VOR outside the scan prescription cannot be used in the quantitative PET 
image reconstruction(106).  As illustrated in Fig 32, the volume of response and, therefore, 
the count profile at the axial extends of prescribed scan regions are limited by the attenuation 
correction unavailability rather than limited by the acquisition geometry.  Similar to the ideal 
CBM case, following equation (1), the count profile for observed CBM mode can be 
expressed as: 
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𝐶(𝑧) ∝ 3𝑧2𝑣 − 𝑧22𝐿𝑣                       ,𝑓𝑜𝑟 0 ≤ 𝑧 ≤ 𝐿, 
𝐶(𝑧) ∝ 𝐿
𝑣
                                     ,𝑓𝑜𝑟 𝐿 ≤ 𝑧 ≤ 𝐿 + 𝑑, 
𝐶(𝑧) ∝ 3𝑧′2𝑣 − 𝑧′22𝐿𝑣                      ,𝑓𝑜𝑟 𝐿 + 𝑑 ≤ 𝑧 ≤ 2𝐿 + 𝑑, 
  
 
(3) 
Note that contrary to the ideal CBM case, in practice 𝐶(0) = 0. 
 
 
Fig 32.  (A) The variation of the volume of response (VOR) at location 𝒛 = 𝟎.𝟒𝑳 (black dot) 
at time t is illustrated by the empty and shaded triangles for ideal and practical cases, 
respectively.  Note that the continuous-bed-motion (CBM) acquisition starts with the edge of 
the prescribed scan region located at the center of the axial field of view.  (B) Graph of the 
VOR and (C) net counts at location 𝒛 as function of time in the ideal CBM (solid blue) and 
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practical CBM (red dash) modes.  The variation in VOR at time points illustrated (A) are 
indicated in (B).  As expected the counts are lower in the practical CBM at the ramping up 
and down regions.  The profiles are derived for a CBM acquisition with 50% overscan. 
 
A.1.2.1.3.Analytic comparison of counting efficiencies in SS and CBM modes 
We compared the count efficiencies of three different modes of PET data 
acquisition: 3D SS acquisition for 1 aFOV, 2 aFOVs, and CBM acquisition for the same 
acquisition duration.  For 2-aFOV scan, the acquisition duration for each bed position was 
half of the acquisition duration in 1-aFOV scan to maintain the same total duration.  The scan 
lengths for 1-aFOV, 2-aFOV, and CBM were 22, 35, and 24 cm, respectively.  The scan 
length of 24 cm was chosen for CBM to provide a scan length similar to 1-aFOV while 
maintaining scan duration of 40 min at the slowest bed speed of 0.1 mm/s. 
 
A.1.2.2. Experimental verification of counting efficiencies in SS and CBM modes 
All PET/CT images were acquired using Siemens Biograph mCT Flow featuring 
the CBM acquisition mode (Flow Motion).  The scanner has a bore diameter of 78 𝑐𝑚 and an 
axial field of view (aFOV) of 22-𝑐𝑚 (4-ring detector configuration).  The system is also 
time-of-flight (TOF) capable with nominal timing resolution of 0.555 𝑛𝑠. 
A 2-mCi 68Ge daily QC phantom with length of 27 cm and diameter of 20 cm was 
scanned using 3 PET acquisition modes described previously: 1 and 2-aFOV SS, and CBM 
modes to derive the count density profiles of each mode.  The acquisition parameters were 
the same as those used for analytical comparison (Material and Method section 1c).  All 
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PET/CT images were reconstructed using TOF information with CT attenuation correction, 
PSF modeling, scatter correction, and OSEM iterative reconstruction (TrueX, Siemens 
Medical Solutions) with subset and iteration of 2 × 21. 
For all transaxial slices, the means and standard deviations of the reconstructed 
activity concentration were extracted from a 40-cm2 ROI placed at the center of the phantom 
images.  Based on our observation, the PET image noise follows a Poisson-like distribution, 
i.e., 𝑖𝑚𝑎𝑔𝑒 𝑛𝑜𝑖𝑠𝑒 ∝ 𝑐𝑜𝑢𝑛𝑡𝑠−0.51; therefore the relative count density profiles were 
computed from the relative noise measurements of the ROIs as: 
𝐶 ∝
1
𝜎𝑟𝑒𝑙
2 = �𝑚𝑒𝑎𝑛𝑠𝑡𝑑𝑒𝑣�2.  (4) 
The relative count profiles along z axis were calculated for all 3 PET acquisition 
modes.  These relative count profiles were then compared to the analytically derived count 
profiles (Material and Method section 1b) for validation. 
 
A.1.3.  Results 
A.1.3.1.  Comparison of the sensitivity profiles in CBM and SS modes 
The theoretically derived count density profiles are shown together with the 
experimentally computed count profiles for 1- and 2-aFOV SS, and CBM modes in Fig 33.  
The measured profiles for 1-aFOV and CBM with axial scan lengths of 22 cm and 24 cm, 
respectively, are in good agreement with the theoretically derived profiles. However, the 
measured profile for 2-aFOV with axial scan length of 35 cm is not fully characterized in the 
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axial direction because the phantom used for the measurements is shorter in length (only ~27 
cm). Nonetheless, agreement between measured and theoretical profiles for SS 2-aFOV scans 
can be fully appreciated in the positive positions where the phantom extends fully.  The 
measured profiles are noisy while the analytically profiles were derived under idealized 
assumptions, yet there is reasonably good agreement between them. 
The measured profile from CBM acquisition has been demonstrated to be less 
efficient compared to the ideal CBM case, as explained in Materials and Methods section 1b, 
due to unusable data due to missing attenuation correction factor in the overscan region.  For 
fixed scan durations, the overall counting efficiency of CBM mode is lower compared to 
those of 1- and 2-aFOV SS acquisition modes in terms of total PET signal (area under the 
curves). CBM mode only acquired ~60% of the total counts acquired in the SS acquisition 
modes for the same acquisition duration.  In addition, for the same acquisition duration, the 
ratio of the maximum counts in the CBM to 1-aFOV SS modes is proportional to 𝑎𝐹𝑂𝑉/ (2 × 𝑠𝑐𝑎𝑛 𝑙𝑒𝑛𝑔𝑡ℎ𝐶𝐵𝑀), i.e.,  the maximum-count images in the CBM is ≤ 50% of those for 
1-aFOV SS mode, and ≤ 100% of those for 2-aFOV SS mode. 
 
 
123 
 
 Fig 33. (A) Comparison of the analytically derived counting efficiencies for a uniform line 
cylindrical source acquired using step-and shoot (SS) acquisition mode (scan lengths of 1 and 
2 aFOVs) and continuous bed motion (CBM) mode.  All profiles are aligned at the central 
slices to compare the trade-off between counts and scan length.  The ideal CBM profile (red 
dash) shows the counting efficiency for a geometry-limited CBM mode, while observed 
CBM profile (solid red line) shows the counting efficiency realized in the CBM mode with 
missing attenuation correction in the overscan region.  (B) The profiles from analytical 
derivation (dash line) showing good agreement with the experimentally derived count 
profiles (solid line) for 1- and 2-aFOV SS, and CBM acquisition modes.  The counting 
efficiency of CBM mode is less efficient compared to the SS mode.  The measured profiles 
for 1-aFOV and CBM with axial scan lengths of 22 cm and 24 cm, respectively, are in good 
agreement with the theoretically derived profiles. However, the measured profile for 2-aFOV 
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with axial scan length of 35 cm is not fully characterized in the axial direction because the 
phantom used for the measurements is shorter in length (only ~27 cm). 
For a short scan length of 1 aFOV, i.e., ~22 𝑐𝑚, a plateau of lower relative noise 
(based on the relative count density profiles) with 1-aFOV SS mode was realized for a region 
of ~14 𝑐𝑚 around the center of the axial FOV. The extent of the lower noise plateau region 
decreased to ~10 𝑐𝑚 for 2-aFOV SS and CBM modes.  The 2-aFOV SS mode, however, 
does provide 11 cm additional axial scan coverage than CBM mode, i.e., 35 cm compared to 
24 cm, for the same acquisition time. 
 
A.1.4.  Discussion 
A.1.4.1.  Effects of acquisition modes on image quality and quantitation 
Both SS and CBM PET acquisition modes allow for trade-off between the counts 
per unit (axial) distance and scan length for fixed acquisition duration. With SS mode the 
increments in scan length are in terms on a fixed fraction of PET aFOV depending on the 
prescribed bed-overlap; with CBM, however, the scan length can be increased in increments 
of prescribed table speed allowed. For the same acquisition duration, the maximum count 
efficiency (at the central images) for CBM mode is less than or equal to half of that for 1-
aFOV SS acquisition mode and less than or equal to the maximum count efficiency for 2-
aFOV SS acquisition mode. For the same scan length and scan duration, CBM mode only 
collected ~60% coincidence counts that are collected in the 1-aFOV SS mode. For the same 
acquisition duration, the maximum count efficiency of a 2-aFOV SS acquisition relative to a 
1-aFOV SS mode depends on the amount of bed overlap; it is half for 50% bed-overlap.   
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 A.1.4.2. CBM versus SS modes for organ scan 
The primary advantages of the CBM mode compared to the SS mode are that the 
CBM mode offers uniform axial sensitivity profile and it facilitates effective trading between 
scan length and scan duration.  These advantages, however, are not realized in scans of 
limited axial coverage such as scans of liver or other organs.  For organ studies with scan 
lengths less than ~30 𝑐𝑚, tailor fitting the scan length becomes less practical.  As discussed 
in detail in the material and method section 1, the CBM count density is not uniform for the 
first and the last halves of the aFOV.  For a scan length ≤ 2 aFOV, these non-uniform 
regions comprise ≥ 50% of the total scan length. 
The usefulness of CBM mode is even more restricted in studies with short scan 
length and long scan duration such as 90Y liver PET/CT (10 − 30 𝑚𝑖𝑛/𝑏𝑒𝑑). The slowest 
speed setting in CBM is 0.1 𝑚𝑚/𝑠 and the speed has the finest increment of 0.1 𝑚𝑚/𝑠.  For 
a typical liver length of 24 𝑐𝑚, the scan duration can be set to a maximum of 40 𝑚𝑖𝑛.  Since 
the next available speed setting is 0.2 𝑚𝑚/𝑠, the next available duration to cover the 24-cm 
liver scan is 20 𝑚𝑖𝑛.  Due to its finite bed speed increments, CBM mode losses its ability to 
effectively trade scan lengths and durations for exams requiring long scan durations such as 
90Y PET/CT.  For a short scan with long duration, SS mode gives greater flexibility in 
scanning duration with net higher counts detected for 1-aFOV scan length, and net longer 
scan length coverage with at least comparable net counts for 2-aFOV scan length. 
For a count-starved study like 90Y PET/CT, the counting efficiency is of importance 
because the image quality and quantification are strongly dependent on the number of 
coincidence count detected during the acquisition.  Since SS acquisition has higher counting 
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efficiency compared to CBM mode, SS acquisition is more suitable for organ scan with 
limited scan length and long scan duration like 90Y liver PET/CT. 
 
 
A.1.4.3. Limitations 
In this work, we presented simplistic models to characterize the counting 
efficiencies across the aFOV both in the SS and CBM modes.  Even though these idealized 
models do not incorporate details(106) about data acquisition, splitting, correction and image 
reconstruction, they were still effective to demonstrate the difference in the counting 
efficiencies between the SS and CBM modes.  
It is important to note that the lack of attenuation information outside the CBM 
aFOV may be overcome by more advanced reconstruction algorithms (e.g., data driven) or 
altering the CBM scan protocol (e.g., operating CBM at high bed speeds at the two end of 
FOV).  Use of attenuation corrected PET signal from outside the CBM scan prescription will 
help push CBM sensitivity profile similar to that of 2-aFOV SS in central region (as shown in 
Figure 3A).  
The primary objective of this study was to optimize the acquisition protocol for 
post-therapy microsphere 90Y-PET/CT studies; we, however, used 68Ge phantom as a 
surrogate radionuclide.  68Ge and 90Y may have differences in the absolute sensitivity, scatter 
properties, singles, random coincidence, and resolution; nevertheless, the relative counting 
efficiency in different acquisition modes should be similar.  Using 68Ge instead of 90Y 
allowed us to acquire higher counts in shorter duration with lower radioactivity. 
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A.1.4.4. Conclusion 
The benefits of CBM mode is severely challenged in studies with short scan length 
(≤ 30 𝑐𝑚), due to non-uniform count density in the first and the last halves of the aFOV, and 
long scan duration (20 𝑚𝑖𝑛/𝑎𝐹𝑂𝑉), due to limitation in the bed speed increment of 0.1 𝑚𝑚/
𝑠.  The SS acquisition mode is preferable to CBM mode for count-starved 90Y-PET/CT livers 
scans due to having higher counting efficiency, which will lead to better image quality and 
quantification precision. 
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